SLC3A2

UniProt ID: P08195
Organism: Homo sapiens
Review Status: COMPLETE
šŸ“ Provide Detailed Feedback

Gene Description

SLC3A2 (also known as 4F2hc, CD98 heavy chain) encodes the essential heavy chain subunit of heteromeric amino acid transporters (HATs). It functions as a type II transmembrane glycoprotein that forms disulfide-linked heterodimers with various SLC7 family light chain transporters (SLC7A5/LAT1, SLC7A6/y+LAT2, SLC7A7/y+LAT1, SLC7A8/LAT2, SLC7A10/Asc-1, SLC7A11/xCT). SLC3A2 acts as a chaperone essential for the trafficking, plasma membrane localization, and stability of these light chain partners, which provide the actual catalytic transport activity. The SLC3A2/SLC7A5 (LAT1) complex mediates Na+-independent transport of large neutral amino acids (leucine, phenylalanine, tryptophan, tyrosine) and is critical for mTORC1 activation. The SLC3A2/SLC7A11 (xCT) complex functions as the cystine/glutamate antiporter system xc-, important for glutathione synthesis and protection against ferroptosis. SLC3A2 also modulates integrin signaling independently of its transport functions. High-resolution cryo-EM structures have elucidated the molecular architecture of these complexes.

Existing Annotations Review

GO Term Evidence Action Reason
GO:1903801 L-leucine import across plasma membrane
IBA
GO_REF:0000033
ACCEPT
Summary: SLC3A2 partners with LAT1 (SLC7A5) and LAT2 (SLC7A8) to form heterodimeric amino acid transporters that mediate leucine import. This is a core function well-supported by phylogenetic analysis and experimental evidence from multiple studies (PMID:9751058, PMID:10574970, PMID:11557028, PMID:30867591).
Reason: L-leucine import is a well-established core function of SLC3A2-containing heterodimeric transporters. The IBA annotation is consistent with extensive experimental evidence.
Supporting Evidence:
PMID:9751058
Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family.
PMID:30867591
Mar 13. Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex.
file:human/SLC3A2/SLC3A2-deep-research-falcon.md
model: Edison Scientific Literature
GO:0015823 phenylalanine transport
IBA
GO_REF:0000033
ACCEPT
Summary: Phenylalanine is a well-established substrate for the LAT1-4F2hc and LAT2-4F2hc complexes. Multiple experimental studies confirm phenylalanine transport activity.
Reason: Phenylalanine transport is a core function of SLC3A2-containing HAT complexes, supported by phylogenetic and experimental evidence.
Supporting Evidence:
PMID:10574970
LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine.
PMID:11557028
Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines.
GO:0016323 basolateral plasma membrane
IBA
GO_REF:0000033
ACCEPT
Summary: SLC3A2 localizes to both apical and basolateral plasma membranes in polarized epithelial cells. Basolateral localization is well-documented for kidney and intestinal epithelia where it partners with LAT2.
Reason: Basolateral localization is supported by phylogenetic inference and consistent with experimental data from polarized epithelial cells (PMID:31791063).
Supporting Evidence:
PMID:31791063
Quantitative Protein Expression in the Human Retinal Pigment Epithelium: Comparison Between Apical and Basolateral Plasma Membranes With Emphasis on Transporters.
GO:0016324 apical plasma membrane
IBA
GO_REF:0000033
ACCEPT
Summary: SLC3A2 is found at the apical membrane of syncytiotrophoblasts and other polarized cells. Apical localization depends on the light chain partner.
Reason: Apical localization is well-documented in multiple cell types and tissues.
Supporting Evidence:
PMID:31791063
Quantitative Protein Expression in the Human Retinal Pigment Epithelium: Comparison Between Apical and Basolateral Plasma Membranes With Emphasis on Transporters.
GO:1904273 L-alanine import across plasma membrane
IBA
GO_REF:0000033
ACCEPT
Summary: L-alanine transport is mediated by the LAT2-4F2hc complex. LAT2 has broader specificity for small and large neutral amino acids compared to LAT1.
Reason: L-alanine import is established function of the SLC3A2/LAT2 complex based on experimental evidence (PMID:10391915).
Supporting Evidence:
PMID:10391915
Identification of a membrane protein, LAT-2, that Co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids.
GO:0001618 virus receptor activity
IEA
GO_REF:0000043
KEEP AS NON CORE
Summary: SLC3A2/CD98 has been demonstrated to act as a receptor for Plasmodium vivax entry into immature red blood cells (PMID:34294905) and facilitates hepatitis C virus entry (PMID:30341327). This represents a secondary function exploited by pathogens.
Reason: While virus/pathogen receptor activity is experimentally validated, it represents exploitation of SLC3A2 by pathogens rather than a core physiological function.
Supporting Evidence:
PMID:34294905
2021 Jul 22. Plasmodium vivax binds host CD98hc (SLC3A2) to enter immature red blood cells.
PMID:30341327
Hepatitis C Virus Modulates Solute carrier family 3 member 2 for Viral Propagation.
GO:0005765 lysosomal membrane
IEA
GO_REF:0000044
ACCEPT
Summary: SLC3A2 is recruited to lysosomes by LAPTM4B where the LAT1-4F2hc complex promotes leucine uptake into lysosomes, facilitating mTORC1 activation (PMID:25998567).
Reason: Lysosomal localization is experimentally verified and functionally important for mTORC1 signaling.
Supporting Evidence:
PMID:25998567
LAPTM4b recruits the LAT1-4F2hc Leu transporter to lysosomes and promotes mTORC1 activation.
GO:0005886 plasma membrane
IEA
GO_REF:0000120
ACCEPT
Summary: Plasma membrane localization is the primary site of SLC3A2 function where it forms heterodimeric transporters. Extensively validated by experimental studies and structural biology.
Reason: Core localization supported by cryo-EM structures and numerous functional studies.
Supporting Evidence:
PMID:30867591
Mar 13. Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex.
GO:0005975 carbohydrate metabolic process
IEA
GO_REF:0000002
REMOVE
Summary: This annotation is based on the glycoside hydrolase domain annotation in InterPro. However, SLC3A2 does NOT function as a glycoside hydrolase - it functions as an amino acid transporter chaperone. The alpha-amylase-like fold is structural but not catalytically active. This is an erroneous electronic annotation.
Reason: SLC3A2 does not participate in carbohydrate metabolism. While it contains an alpha-amylase-like domain fold, this domain has been repurposed for structural roles in membrane association and heterodimer formation, not carbohydrate hydrolysis. Recent structural studies (PMID:30867591, PMID:33298890) confirm this domain mediates protein-protein interactions, not enzymatic activity.
Supporting Evidence:
PMID:30867591
Mar 13. Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex.
GO:0006865 amino acid transport
IEA
GO_REF:0000120
ACCEPT
Summary: Amino acid transport is the primary function of SLC3A2 when complexed with SLC7 family light chains. This is a core function.
Reason: Core function well-established by extensive experimental evidence.
GO:0015823 phenylalanine transport
IEA
GO_REF:0000117
ACCEPT
Summary: Duplicate of IBA annotation above. Phenylalanine transport is a well-established substrate for LAT1 and LAT2 complexes with SLC3A2.
Reason: Core function - phenylalanine is a well-characterized substrate.
GO:0015827 tryptophan transport
IEA
GO_REF:0000117
ACCEPT
Summary: Tryptophan is a substrate for LAT1-4F2hc and LAT2-4F2hc complexes. Experimentally verified in multiple studies.
Reason: Core function supported by experimental evidence (PMID:10574970, PMID:11557028, PMID:11564694).
Supporting Evidence:
PMID:10574970
LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine.
GO:0016020 membrane
IEA
GO_REF:0000117
ACCEPT
Summary: Generic membrane annotation. SLC3A2 is a type II transmembrane protein - more specific annotations (plasma membrane, lysosomal membrane) are also present.
Reason: Valid but general annotation. More specific CC annotations are preferable.
GO:0016323 basolateral plasma membrane
IEA
GO_REF:0000044
ACCEPT
Summary: Duplicate of IBA annotation. Valid localization for SLC3A2 in polarized epithelial cells.
Reason: Well-supported localization.
GO:0016324 apical plasma membrane
IEA
GO_REF:0000044
ACCEPT
Summary: Duplicate of IBA annotation. Valid localization.
Reason: Well-supported localization in polarized cells.
GO:0042470 melanosome
IEA
GO_REF:0000044
KEEP AS NON CORE
Summary: SLC3A2 was identified in melanosome proteomics studies. This likely reflects amino acid transporter activity in these specialized organelles.
Reason: Melanosome localization is based on proteomics data but not a core localization.
GO:0046982 protein heterodimerization activity
IEA
GO_REF:0000117
ACCEPT
Summary: Heterodimerization with SLC7 family members is THE core molecular function of SLC3A2. It forms obligate disulfide-linked heterodimers with light chains.
Reason: Core molecular function. SLC3A2 forms heterodimers with at least 6 different SLC7 family members (SLC7A5, SLC7A6, SLC7A7, SLC7A8, SLC7A10, SLC7A11).
Supporting Evidence:
PMID:30867591
Mar 13. Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex.
PMID:34880232
Molecular basis for redox control by the human cystine/glutamate antiporter system xc().
GO:0070161 anchoring junction
IEA
GO_REF:0000044
KEEP AS NON CORE
Summary: SLC3A2 localizes to cell-cell adhesion sites and interacts with integrins. This relates to its integrin signaling modulation function.
Reason: Junction localization is secondary to its transport function.
GO:0005515 protein binding
IPI
PMID:20374249
The pathogenic E. coli type III effector EspZ interacts with...
MARK AS OVER ANNOTATED
Summary: This annotation is based on interaction with E. coli EspZ effector protein. Represents pathogen exploitation of SLC3A2.
Reason: Generic protein binding annotation - more specific MF terms exist for the relevant interactions (heterodimerization with SLC7 proteins).
Supporting Evidence:
PMID:20374249
The pathogenic E. coli type III effector EspZ interacts with host CD98 and facilitates host cell prosurvival signalling.
GO:0005515 protein binding
IPI
PMID:28298427
Systematic protein-protein interaction mapping for clinicall...
MARK AS OVER ANNOTATED
Summary: Interaction with GPR37. Represents a GPCR interaction study.
Reason: Generic protein binding - should be replaced with more specific term if functional significance is established.
Supporting Evidence:
PMID:28298427
Systematic protein-protein interaction mapping for clinically relevant human GPCRs.
GO:0005515 protein binding
IPI
PMID:30867591
Structure of the human LAT1-4F2hc heteromeric amino acid tra...
MODIFY
Summary: Structural study demonstrating interaction with SLC7A5/LAT1.
Reason: This is heterodimerization with SLC7A5 - should use GO:0046982 protein heterodimerization activity, which is also present.
Supporting Evidence:
PMID:30867591
Mar 13. Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex.
GO:0005515 protein binding
IPI
PMID:34880232
Molecular basis for redox control by the human cystine/gluta...
MODIFY
Summary: Structural study of xCT/SLC7A11 interaction with SLC3A2.
Reason: This is heterodimerization - more specific term exists.
Supporting Evidence:
PMID:34880232
Molecular basis for redox control by the human cystine/glutamate antiporter system xc().
GO:0005515 protein binding
IPI
PMID:35271311
OpenCell: Endogenous tagging for the cartography of human ce...
MARK AS OVER ANNOTATED
Summary: OpenCell high-throughput study detecting LAT1 interaction.
Reason: Generic protein binding from HT study - heterodimerization terms are more informative.
Supporting Evidence:
PMID:35271311
2022 Mar 11. OpenCell: Endogenous tagging for the cartography of human cellular organization.
GO:0005515 protein binding
IPI
PMID:40355756
The solute carrier superfamily interactome.
MARK AS OVER ANNOTATED
Summary: SLC transporter interactome study.
Reason: Generic protein binding - specific interactions should use more specific terms.
Supporting Evidence:
PMID:40355756
2025 May 12. The solute carrier superfamily interactome.
GO:0005515 protein binding
IPI
PMID:9878049
Amino acid transport of y+L-type by heterodimers of 4F2hc/CD...
MODIFY
Summary: Early study establishing y+LAT interaction with 4F2hc.
Reason: This demonstrates heterodimerization with SLC7A7.
Supporting Evidence:
PMID:9878049
Amino acid transport of y+L-type by heterodimers of 4F2hc/CD98 and members of the glycoprotein-associated amino acid transporter family.
GO:0015820 L-leucine transport
IEA
GO_REF:0000107
ACCEPT
Summary: Leucine transport is a core function of SLC3A2-containing complexes, especially LAT1-4F2hc. Critical for mTORC1 signaling.
Reason: Well-established core function.
GO:0042803 protein homodimerization activity
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: Crystal structure of the SLC3A2 ectodomain (PMID:17724034) shows it can form homodimers, though heterodimer formation with SLC7 proteins is its primary functional form.
Reason: Homodimerization has been structurally observed but heterodimerization with SLC7 light chains is the functional form.
Supporting Evidence:
GO:0043025 neuronal cell body
IEA
GO_REF:0000107
ACCEPT
Summary: Neuronal localization transferred from mouse ortholog. SLC3A2/LAT1 is expressed in neurons and at the blood-brain barrier.
Reason: Neuronal expression is well-documented for amino acid transport functions.
GO:0044225 apical pole of neuron
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: Specific neuronal localization from ortholog transfer.
Reason: Valid but cell-type specific localization.
GO:0045202 synapse
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: Synaptic localization likely reflects amino acid transporter function at synapses. Asc-1/CD98hc transports D-serine and glycine, key NMDAR co-agonists.
Reason: Synaptic localization is relevant for neuromodulator transport.
GO:0005886 plasma membrane
IDA
GO_REF:0000052
ACCEPT
Summary: HPA immunofluorescence data confirming plasma membrane localization.
Reason: Core localization validated by immunofluorescence.
GO:0089718 amino acid import across plasma membrane
NAS
PMID:10734121
Identification and characterization of a Na(+)-independent n...
ACCEPT
Summary: Small neutral amino acid transporter asc-2/SLC7A10 association with 4F2hc for amino acid import.
Reason: Amino acid import is a core function of SLC3A2-containing transporters.
Supporting Evidence:
PMID:10734121
Identification and characterization of a Na(+)-independent neutral amino acid transporter that associates with the 4F2 heavy chain and exhibits substrate selectivity for small neutral D- and L-amino acids.
GO:0089718 amino acid import across plasma membrane
IDA
PMID:10903140
The heterodimeric amino acid transporter 4F2hc/y+LAT2 mediat...
ACCEPT
Summary: Demonstrates arginine efflux in exchange with glutamine via y+LAT2/4F2hc.
Reason: Core function - amino acid exchange across plasma membrane.
Supporting Evidence:
PMID:10903140
The heterodimeric amino acid transporter 4F2hc/y+LAT2 mediates arginine efflux in exchange with glutamine.
GO:0089718 amino acid import across plasma membrane
IDA
PMID:11417227
Identification and characterisation of human xCT that co-exp...
ACCEPT
Summary: Key paper identifying xCT/SLC7A11 as the partner of 4F2hc for system xc- activity (cystine/glutamate antiporter). Cystine import is critical.
Reason: Core function - cystine import is essential for glutathione synthesis.
Supporting Evidence:
PMID:11417227
Identification and characterisation of human xCT that co-expresses, with 4F2 heavy chain, the amino acid transport activity system xc-.
GO:0089718 amino acid import across plasma membrane
IDA
PMID:30867591
Structure of the human LAT1-4F2hc heteromeric amino acid tra...
ACCEPT
Summary: Cryo-EM structure of LAT1-4F2hc complex with functional characterization.
Reason: Core function supported by structural and functional studies.
Supporting Evidence:
PMID:30867591
Mar 13. Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex.
GO:0089718 amino acid import across plasma membrane
IDA
PMID:33758168
Mechanism of substrate transport and inhibition of the human...
ACCEPT
Summary: Mechanism of substrate transport and inhibition of LAT1-4F2hc.
Reason: Core function with mechanistic detail.
Supporting Evidence:
PMID:33758168
Mechanism of substrate transport and inhibition of the human LAT1-4F2hc amino acid transporter.
GO:0089718 amino acid import across plasma membrane
IDA
PMID:9878049
Amino acid transport of y+L-type by heterodimers of 4F2hc/CD...
ACCEPT
Summary: Early characterization of y+L-type transport by 4F2hc heterodimers.
Reason: Foundational paper establishing amino acid transport function.
Supporting Evidence:
PMID:9878049
Amino acid transport of y+L-type by heterodimers of 4F2hc/CD98 and members of the glycoprotein-associated amino acid transporter family.
GO:0150104 transport across blood-brain barrier
NAS
PMID:27912058
Impaired Amino Acid Transport at the Blood Brain Barrier Is ...
KEEP AS NON CORE
Summary: LAT1-4F2hc at the blood-brain barrier transports essential amino acids. Impaired transport is linked to autism spectrum disorder.
Reason: Tissue-specific function reflecting amino acid transport at BBB.
Supporting Evidence:
PMID:27912058
Impaired Amino Acid Transport at the Blood Brain Barrier Is a Cause of Autism Spectrum Disorder.
GO:0046982 protein heterodimerization activity
IDA
PMID:33298890
Structural insight into the substrate recognition and transp...
ACCEPT
Summary: Cryo-EM structure of LAT2-4F2hc complex demonstrating heterodimer architecture.
Reason: Core molecular function directly demonstrated by structural biology.
Supporting Evidence:
PMID:33298890
Structural insight into the substrate recognition and transport mechanism of the human LAT2-4F2hc complex.
GO:0140272 exogenous protein binding
IDA
PMID:30341327
Hepatitis C Virus Modulates Solute carrier family 3 member 2...
KEEP AS NON CORE
Summary: Binding to hepatitis C virus envelope proteins facilitating viral entry.
Reason: Pathogen exploitation of SLC3A2 - not a core function.
Supporting Evidence:
PMID:30341327
Hepatitis C Virus Modulates Solute carrier family 3 member 2 for Viral Propagation.
GO:0140272 exogenous protein binding
IDA
PMID:34294905
Plasmodium vivax binds host CD98hc (SLC3A2) to enter immatur...
KEEP AS NON CORE
Summary: CD98hc serves as a receptor for Plasmodium vivax entry into reticulocytes.
Reason: Pathogen receptor function - exploited by malaria parasite.
Supporting Evidence:
PMID:34294905
2021 Jul 22. Plasmodium vivax binds host CD98hc (SLC3A2) to enter immature red blood cells.
GO:0005515 protein binding
IPI
PMID:33298890
Structural insight into the substrate recognition and transp...
MODIFY
Summary: Interaction with SLC7A8/LAT2 demonstrated structurally.
Reason: Heterodimerization - more specific term available.
Supporting Evidence:
PMID:33298890
Structural insight into the substrate recognition and transport mechanism of the human LAT2-4F2hc complex.
GO:0005886 plasma membrane
IDA
PMID:11311135
Association of 4F2hc with light chains LAT1, LAT2 or y+LAT2 ...
ACCEPT
Summary: Study showing domain requirements for 4F2hc association with LAT1, LAT2, y+LAT2.
Reason: Well-established core localization.
Supporting Evidence:
PMID:11311135
Association of 4F2hc with light chains LAT1, LAT2 or y+LAT2 requires different domains.
GO:0005886 plasma membrane
IDA
PMID:11557028
Human L-type amino acid transporter 1 (LAT1) characterizatio...
ACCEPT
Summary: LAT1 characterization showing plasma membrane localization.
Reason: Core localization.
Supporting Evidence:
PMID:11557028
Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines.
GO:0005886 plasma membrane
IDA
PMID:12225859
Characterization of the system L amino acid transporter in T...
ACCEPT
Summary: System L amino acid transporter in T24 bladder carcinoma cells.
Reason: Core localization.
Supporting Evidence:
PMID:12225859
Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells.
GO:0015818 isoleucine transport
IDA
PMID:11311135
Association of 4F2hc with light chains LAT1, LAT2 or y+LAT2 ...
ACCEPT
Summary: Isoleucine is transported by LAT1-4F2hc and LAT2-4F2hc complexes.
Reason: Core function - isoleucine is a branched-chain amino acid substrate.
Supporting Evidence:
PMID:11311135
Association of 4F2hc with light chains LAT1, LAT2 or y+LAT2 requires different domains.
GO:0015818 isoleucine transport
IDA
PMID:11557028
Human L-type amino acid transporter 1 (LAT1) characterizatio...
ACCEPT
Summary: LAT1 characterization showing isoleucine transport.
Reason: Core function.
Supporting Evidence:
PMID:11557028
Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines.
GO:0015820 L-leucine transport
IDA
PMID:10574970
LAT2, a new basolateral 4F2hc/CD98-associated amino acid tra...
ACCEPT
Summary: LAT2 characterization showing leucine transport.
Reason: Core function - leucine is essential for mTORC1 signaling.
Supporting Evidence:
PMID:10574970
LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine.
GO:0015820 L-leucine transport
IDA
PMID:11557028
Human L-type amino acid transporter 1 (LAT1) characterizatio...
ACCEPT
Summary: LAT1 characterization in tumor cells.
Reason: Core function.
Supporting Evidence:
PMID:11557028
Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines.
GO:0015820 L-leucine transport
IDA
PMID:11564694
Thyroid hormone transport by the heterodimeric human system ...
ACCEPT
Summary: System L transporter characterization.
Reason: Core function.
Supporting Evidence:
PMID:11564694
Thyroid hormone transport by the heterodimeric human system L amino acid transporter.
GO:0015820 L-leucine transport
IDA
PMID:12225859
Characterization of the system L amino acid transporter in T...
ACCEPT
Summary: T24 bladder carcinoma cell characterization.
Reason: Core function.
Supporting Evidence:
PMID:12225859
Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells.
GO:0015820 L-leucine transport
IDA
PMID:15769744
Identification of stereoselective transporters for S-nitroso...
ACCEPT
Summary: S-nitroso-L-cysteine transport via LAT1/LAT2.
Reason: Core function with additional substrate discovery.
Supporting Evidence:
PMID:15769744
2005 Mar 15. Identification of stereoselective transporters for S-nitroso-L-cysteine: role of LAT1 and LAT2 in biological activity of S-nitrosothiols.
GO:0015820 L-leucine transport
IDA
PMID:9751058
Amino-acid transport by heterodimers of 4F2hc/CD98 and membe...
ACCEPT
Summary: Foundational paper establishing 4F2hc permease heterodimer transport.
Reason: Core function - seminal paper.
Supporting Evidence:
PMID:9751058
Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family.
GO:0015821 methionine transport
IDA
PMID:11557028
Human L-type amino acid transporter 1 (LAT1) characterizatio...
ACCEPT
Summary: LAT1 transports methionine, which is important for methylation reactions.
Reason: Core function.
Supporting Evidence:
PMID:11557028
Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines.
GO:0015823 phenylalanine transport
IDA
PMID:10574970
LAT2, a new basolateral 4F2hc/CD98-associated amino acid tra...
ACCEPT
Summary: LAT2 phenylalanine transport characterization.
Reason: Core function.
Supporting Evidence:
PMID:10574970
LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine.
GO:0015823 phenylalanine transport
IDA
PMID:11557028
Human L-type amino acid transporter 1 (LAT1) characterizatio...
ACCEPT
Summary: LAT1 phenylalanine transport.
Reason: Core function.
Supporting Evidence:
PMID:11557028
Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines.
GO:0015823 phenylalanine transport
IDA
PMID:11564694
Thyroid hormone transport by the heterodimeric human system ...
ACCEPT
Summary: System L transporter phenylalanine transport.
Reason: Core function.
Supporting Evidence:
PMID:11564694
Thyroid hormone transport by the heterodimeric human system L amino acid transporter.
GO:0015823 phenylalanine transport
IDA
PMID:9751058
Amino-acid transport by heterodimers of 4F2hc/CD98 and membe...
ACCEPT
Summary: Foundational study on 4F2hc heterodimer transport.
Reason: Core function.
Supporting Evidence:
PMID:9751058
Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family.
GO:0015824 proline transport
IDA
PMID:10574970
LAT2, a new basolateral 4F2hc/CD98-associated amino acid tra...
ACCEPT
Summary: Proline transport by LAT2-4F2hc.
Reason: LAT2 has broader substrate specificity including proline.
Supporting Evidence:
PMID:10574970
LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine.
GO:0015827 tryptophan transport
IDA
PMID:10574970
LAT2, a new basolateral 4F2hc/CD98-associated amino acid tra...
ACCEPT
Summary: Tryptophan transport by LAT2.
Reason: Core function.
Supporting Evidence:
PMID:10574970
LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine.
GO:0015827 tryptophan transport
IDA
PMID:11557028
Human L-type amino acid transporter 1 (LAT1) characterizatio...
ACCEPT
Summary: Tryptophan transport by LAT1.
Reason: Core function - large neutral aromatic amino acid.
Supporting Evidence:
PMID:11557028
Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines.
GO:0015827 tryptophan transport
IDA
PMID:11564694
Thyroid hormone transport by the heterodimeric human system ...
ACCEPT
Summary: System L tryptophan transport.
Reason: Core function.
Supporting Evidence:
PMID:11564694
Thyroid hormone transport by the heterodimeric human system L amino acid transporter.
GO:0015828 tyrosine transport
IDA
PMID:11557028
Human L-type amino acid transporter 1 (LAT1) characterizatio...
ACCEPT
Summary: Tyrosine transport by LAT1.
Reason: Core function - aromatic amino acid.
Supporting Evidence:
PMID:11557028
Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines.
GO:0015828 tyrosine transport
IDA
PMID:11564694
Thyroid hormone transport by the heterodimeric human system ...
ACCEPT
Summary: System L tyrosine transport.
Reason: Core function.
Supporting Evidence:
PMID:11564694
Thyroid hormone transport by the heterodimeric human system L amino acid transporter.
GO:0015829 valine transport
IDA
PMID:11557028
Human L-type amino acid transporter 1 (LAT1) characterizatio...
ACCEPT
Summary: Valine transport by LAT1.
Reason: Core function - branched-chain amino acid.
Supporting Evidence:
PMID:11557028
Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines.
GO:0070327 thyroid hormone transport
IDA
PMID:11564694
Thyroid hormone transport by the heterodimeric human system ...
KEEP AS NON CORE
Summary: LAT1 and LAT2 transport thyroid hormones (T3, T4) which structurally resemble tyrosine.
Reason: Valid function but secondary to amino acid transport - thyroid hormones are structurally similar to tyrosine.
Supporting Evidence:
PMID:11564694
Thyroid hormone transport by the heterodimeric human system L amino acid transporter.
GO:1902024 L-histidine transport
IDA
PMID:11557028
Human L-type amino acid transporter 1 (LAT1) characterizatio...
ACCEPT
Summary: Histidine transport by LAT1.
Reason: Core function.
Supporting Evidence:
PMID:11557028
Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines.
GO:1902024 L-histidine transport
IDA
PMID:9751058
Amino-acid transport by heterodimers of 4F2hc/CD98 and membe...
ACCEPT
Summary: Histidine transport by 4F2hc heterodimers.
Reason: Core function.
Supporting Evidence:
PMID:9751058
Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family.
GO:0005515 protein binding
IPI
PMID:30341327
Hepatitis C Virus Modulates Solute carrier family 3 member 2...
KEEP AS NON CORE
Summary: Interaction with HCV E2 envelope protein.
Reason: Pathogen interaction - exogenous protein binding term more appropriate.
Supporting Evidence:
PMID:30341327
Hepatitis C Virus Modulates Solute carrier family 3 member 2 for Viral Propagation.
GO:0015820 L-leucine transport
IMP
PMID:30341327
Hepatitis C Virus Modulates Solute carrier family 3 member 2...
ACCEPT
Summary: Leucine transport enhanced during HCV infection promoting mTORC1 signaling.
Reason: Core function demonstrated by mutant phenotype.
Supporting Evidence:
PMID:30341327
Hepatitis C Virus Modulates Solute carrier family 3 member 2 for Viral Propagation.
GO:0046718 symbiont entry into host cell
IMP
PMID:30341327
Hepatitis C Virus Modulates Solute carrier family 3 member 2...
KEEP AS NON CORE
Summary: SLC3A2 facilitates HCV entry into host cells.
Reason: Pathogen exploitation function - not a normal physiological role.
Supporting Evidence:
PMID:30341327
Hepatitis C Virus Modulates Solute carrier family 3 member 2 for Viral Propagation.
GO:0005886 plasma membrane
IDA
PMID:28112518
LC-MS/MS Based Quantitation of ABC and SLC Transporter Prote...
ACCEPT
Summary: Mass spectrometry quantitation in retinal pigment epithelial cells.
Reason: Core localization.
Supporting Evidence:
PMID:28112518
Epub 2017 Feb 14. LC-MS/MS Based Quantitation of ABC and SLC Transporter Proteins in Plasma Membranes of Cultured Primary Human Retinal Pigment Epithelium Cells and Immortalized ARPE19 Cell Line.
GO:0015180 L-alanine transmembrane transporter activity
IGI
PMID:10391915
Identification of a membrane protein, LAT-2, that Co-express...
ACCEPT
Summary: LAT2-4F2hc complex transports alanine - shown by co-expression with SLC7A8.
Reason: Core molecular function demonstrated by genetic interaction.
Supporting Evidence:
PMID:10391915
Identification of a membrane protein, LAT-2, that Co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids.
GO:0015190 L-leucine transmembrane transporter activity
IGI
PMID:10391915
Identification of a membrane protein, LAT-2, that Co-express...
ACCEPT
Summary: LAT2-4F2hc leucine transporter activity.
Reason: Core molecular function.
Supporting Evidence:
PMID:10391915
Identification of a membrane protein, LAT-2, that Co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids.
GO:1903801 L-leucine import across plasma membrane
IGI
PMID:10391915
Identification of a membrane protein, LAT-2, that Co-express...
ACCEPT
Summary: Leucine import by LAT2-4F2hc.
Reason: Core function.
Supporting Evidence:
PMID:10391915
Identification of a membrane protein, LAT-2, that Co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids.
GO:1904273 L-alanine import across plasma membrane
IGI
PMID:10391915
Identification of a membrane protein, LAT-2, that Co-express...
ACCEPT
Summary: Alanine import by LAT2-4F2hc.
Reason: Core function.
Supporting Evidence:
PMID:10391915
Identification of a membrane protein, LAT-2, that Co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids.
GO:0009925 basal plasma membrane
ISS
GO_REF:0000024
ACCEPT
Summary: Basal membrane localization inferred from sequence similarity.
Reason: Valid localization consistent with basolateral distribution.
GO:0016323 basolateral plasma membrane
IDA
PMID:31791063
Quantitative Protein Expression in the Human Retinal Pigment...
ACCEPT
Summary: Direct experimental evidence for basolateral localization in RPE cells.
Reason: Core localization validated experimentally.
Supporting Evidence:
PMID:31791063
Quantitative Protein Expression in the Human Retinal Pigment Epithelium: Comparison Between Apical and Basolateral Plasma Membranes With Emphasis on Transporters.
GO:0016324 apical plasma membrane
ISS
GO_REF:0000024
ACCEPT
Summary: Apical localization from sequence similarity.
Reason: Valid localization.
GO:0016324 apical plasma membrane
IDA
PMID:31791063
Quantitative Protein Expression in the Human Retinal Pigment...
ACCEPT
Summary: Direct evidence for apical localization in RPE cells.
Reason: Core localization validated experimentally.
Supporting Evidence:
PMID:31791063
Quantitative Protein Expression in the Human Retinal Pigment Epithelium: Comparison Between Apical and Basolateral Plasma Membranes With Emphasis on Transporters.
GO:0015173 aromatic amino acid transmembrane transporter activity
IGI
PMID:15589117
Human LAT1 single nucleotide polymorphism N230K does not alt...
ACCEPT
Summary: LAT1-4F2hc aromatic amino acid transporter activity demonstrated.
Reason: Core molecular function - LAT1 preferentially transports large neutral aromatics.
Supporting Evidence:
PMID:15589117
Human LAT1 single nucleotide polymorphism N230K does not alter phenylalanine transport.
GO:0015823 phenylalanine transport
IGI
PMID:15589117
Human LAT1 single nucleotide polymorphism N230K does not alt...
ACCEPT
Summary: Phenylalanine transport by LAT1-4F2hc.
Reason: Core function.
Supporting Evidence:
PMID:15589117
Human LAT1 single nucleotide polymorphism N230K does not alter phenylalanine transport.
GO:0015175 neutral L-amino acid transmembrane transporter activity
IGI
PMID:17197568
Ornithine transport via cationic amino acid transporter-1 is...
ACCEPT
Summary: Neutral amino acid transporter activity demonstrated for SLC3A2-containing complexes.
Reason: Core molecular function.
Supporting Evidence:
PMID:17197568
Ornithine transport via cationic amino acid transporter-1 is involved in ornithine cytotoxicity in retinal pigment epithelial cells.
GO:1903801 L-leucine import across plasma membrane
IGI
PMID:17197568
Ornithine transport via cationic amino acid transporter-1 is...
ACCEPT
Summary: Leucine import function.
Reason: Core function.
Supporting Evidence:
PMID:17197568
Ornithine transport via cationic amino acid transporter-1 is involved in ornithine cytotoxicity in retinal pigment epithelial cells.
GO:0005886 plasma membrane
IDA
PMID:23137377
Quantitative targeted absolute proteomic analysis of transpo...
ACCEPT
Summary: Quantitative proteomics in cerebral microvascular endothelial cells.
Reason: Core localization at blood-brain barrier.
Supporting Evidence:
PMID:23137377
Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model.
GO:1990184 amino acid transport complex
IDA
PMID:30867591
Structure of the human LAT1-4F2hc heteromeric amino acid tra...
ACCEPT
Summary: Cryo-EM structure directly demonstrating SLC3A2 as part of heteromeric amino acid transporter complex.
Reason: Core function - SLC3A2 is an obligate component of HAT complexes.
Supporting Evidence:
PMID:30867591
Mar 13. Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex.
GO:0045296 cadherin binding
HDA
PMID:25468996
E-cadherin interactome complexity and robustness resolved by...
KEEP AS NON CORE
Summary: High-throughput study identifying E-cadherin interactome. SLC3A2 localized to cell-cell junctions.
Reason: Secondary function related to cell adhesion role.
Supporting Evidence:
PMID:25468996
E-cadherin interactome complexity and robustness resolved by quantitative proteomics.
GO:0005515 protein binding
IPI
PMID:25998567
LAPTM4b recruits the LAT1-4F2hc Leu transporter to lysosomes
ACCEPT
Summary: Interaction with LAPTM4B for lysosomal recruitment.
Reason: Functionally important interaction for mTORC1 activation.
Supporting Evidence:
PMID:25998567
LAPTM4b recruits the LAT1-4F2hc Leu transporter to lysosomes and promotes mTORC1 activation.
GO:0005886 plasma membrane
IDA
PMID:25998567
LAPTM4b recruits the LAT1-4F2hc Leu transporter to lysosomes
ACCEPT
Summary: Plasma membrane and lysosomal localization study.
Reason: Core localization.
Supporting Evidence:
PMID:25998567
LAPTM4b recruits the LAT1-4F2hc Leu transporter to lysosomes and promotes mTORC1 activation.
GO:0005515 protein binding
IPI
PMID:12270127
Molecular cloning and characterization of CT120, a novel mem...
KEEP AS NON CORE
Summary: Interaction with CT120/TLCD3A.
Reason: Minor interaction - function unclear.
Supporting Evidence:
PMID:12270127
Molecular cloning and characterization of CT120, a novel membrane-associated gene involved in amino acid transport and glutathione metabolism.
GO:0005886 plasma membrane
IDA
PMID:12270127
Molecular cloning and characterization of CT120, a novel mem...
ACCEPT
Summary: Plasma membrane localization.
Reason: Core localization.
Supporting Evidence:
PMID:12270127
Molecular cloning and characterization of CT120, a novel membrane-associated gene involved in amino acid transport and glutathione metabolism.
GO:0009986 cell surface
IDA
PMID:25063885
KSHV attachment and entry are dependent on αVβ3 integrin loc...
ACCEPT
Summary: Cell surface localization detected - relevant for pathogen binding.
Reason: Valid localization term.
Supporting Evidence:
PMID:25063885
2014 Jul 24. KSHV attachment and entry are dependent on αVβ3 integrin localized to specific cell surface microdomains and do not correlate with the presence of heparan sulfate.
GO:0009986 cell surface
HDA
PMID:19581412
Quantitative proteomics identifies a Dab2/integrin module re...
ACCEPT
Summary: Proteomics study on cell surface proteins.
Reason: Valid localization.
Supporting Evidence:
PMID:19581412
Jul 6. Quantitative proteomics identifies a Dab2/integrin module regulating cell migration.
GO:0070062 extracellular exosome
HDA
PMID:23533145
In-depth proteomic analyses of exosomes isolated from expres...
KEEP AS NON CORE
Summary: Detected in prostatic exosomes by proteomics.
Reason: Secondary localization - exosomal presence common for membrane proteins.
Supporting Evidence:
PMID:23533145
2013 Apr 23. In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.
GO:0016020 membrane
HDA
PMID:19946888
Defining the membrane proteome of NK cells.
ACCEPT
Summary: NK cell membrane proteome.
Reason: Valid general localization.
Supporting Evidence:
PMID:19946888
Defining the membrane proteome of NK cells.
GO:0003723 RNA binding
HDA
PMID:22658674
Insights into RNA biology from an atlas of mammalian mRNA-bi...
MARK AS OVER ANNOTATED
Summary: High-throughput mRNA interactome study detected SLC3A2. This is likely non-specific or secondary.
Reason: SLC3A2 is a membrane transporter chaperone with no known RNA-related function. High-throughput RNA binding studies can capture non-specific associations. No structural or functional evidence supports RNA binding.
Supporting Evidence:
PMID:22658674
May 31. Insights into RNA biology from an atlas of mammalian mRNA-binding proteins.
GO:0070062 extracellular exosome
HDA
PMID:19199708
Proteomic analysis of human parotid gland exosomes by multid...
KEEP AS NON CORE
Summary: Parotid gland exosome proteomics.
Reason: Secondary localization.
Supporting Evidence:
PMID:19199708
Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT).
GO:0070062 extracellular exosome
HDA
PMID:19056867
Large-scale proteomics and phosphoproteomics of urinary exos...
KEEP AS NON CORE
Summary: Urinary exosome proteomics.
Reason: Secondary localization.
Supporting Evidence:
PMID:19056867
2008 Dec 3. Large-scale proteomics and phosphoproteomics of urinary exosomes.
GO:0003725 double-stranded RNA binding
IDA
PMID:21266579
Raftlin is involved in the nucleocapture complex to induce p...
KEEP AS NON CORE
Summary: Study on raftlin involvement in poly(I:C)-mediated TLR3 activation found SLC3A2 in nucleocapture complex. This appears to be a specialized immunological context.
Reason: This is a specialized immune function in TLR3 signaling, not a core function of SLC3A2. The dsRNA binding may be indirect through complex formation.
Supporting Evidence:
PMID:21266579
2011 Jan 25. Raftlin is involved in the nucleocapture complex to induce poly(I:C)-mediated TLR3 activation.
GO:0043330 response to exogenous dsRNA
IMP
PMID:21266579
Raftlin is involved in the nucleocapture complex to induce p...
KEEP AS NON CORE
Summary: Involvement in TLR3 response to poly(I:C).
Reason: Specialized immune function, not core transporter role.
Supporting Evidence:
PMID:21266579
2011 Jan 25. Raftlin is involved in the nucleocapture complex to induce poly(I:C)-mediated TLR3 activation.
GO:0070062 extracellular exosome
HDA
PMID:20458337
MHC class II-associated proteins in B-cell exosomes and pote...
KEEP AS NON CORE
Summary: B-cell exosome proteomics.
Reason: Secondary localization.
Supporting Evidence:
PMID:20458337
2010 May 11. MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis.
GO:0005886 plasma membrane
TAS
Reactome:R-HSA-352191
ACCEPT
Summary: Reactome annotation for SLC7A8-mediated uptake with SLC3A2.
Reason: Core localization.
GO:0005886 plasma membrane
TAS
Reactome:R-HSA-352232
ACCEPT
Summary: Reactome annotation for SLC7A5:SLC3A2 transport.
Reason: Core localization.
GO:0005886 plasma membrane
TAS
Reactome:R-HSA-375131
ACCEPT
Summary: Basigin binding to CD98 complex at plasma membrane.
Reason: Valid localization.
GO:0005886 plasma membrane
TAS
Reactome:R-HSA-376200
ACCEPT
Summary: SLC7A10-mediated uptake with SLC3A2.
Reason: Core localization for Asc-1/4F2hc complex.
GO:0005886 plasma membrane
TAS
Reactome:R-HSA-378513
ACCEPT
Summary: SLC7A11-mediated cystine/glutamate exchange - system xc-.
Reason: Core localization for xCT/4F2hc (system xc-).
GO:0005886 plasma membrane
TAS
Reactome:R-HSA-379415
ACCEPT
Summary: SLC7A7:SLC3A2 arginine/leucine exchange.
Reason: Core localization for y+LAT1/4F2hc.
GO:0005886 plasma membrane
TAS
Reactome:R-HSA-379426
ACCEPT
Summary: SLC7A6 (y+LAT2) with SLC3A2.
Reason: Core localization.
GO:0005886 plasma membrane
TAS
Reactome:R-HSA-5660910
ACCEPT
Summary: Defective SLC7A7 pathway annotation.
Reason: Valid localization context.
GO:1903801 L-leucine import across plasma membrane
ISS
GO_REF:0000024
ACCEPT
Summary: Leucine import inferred from sequence similarity.
Reason: Core function consistent with experimental evidence.
GO:0005515 protein binding
IPI
PMID:10506149
Cloning and expression of a b(0,+)-like amino acid transport...
MODIFY
Summary: Cloning of b(0,+)-like transporter (SLC7A9 homolog) associating with 4F2hc.
Reason: This is heterodimerization with SLC7 family member.
Supporting Evidence:
PMID:10506149
Cloning and expression of a b(0,+)-like amino acid transporter functioning as a heterodimer with 4F2hc instead of rBAT.
GO:0005515 protein binding
IPI
PMID:10631289
Cloning and functional characterization of a Na(+)-independe...
MODIFY
Summary: Cloning of asc-1 (SLC7A10) interacting with 4F2hc.
Reason: This is heterodimerization with SLC7A10.
Supporting Evidence:
PMID:10631289
Cloning and functional characterization of a Na(+)-independent, broad-specific neutral amino acid transporter from mammalian intestine.
GO:0015827 tryptophan transport
ISS
GO_REF:0000024
ACCEPT
Summary: Tryptophan transport from sequence similarity.
Reason: Core function consistent with experimental evidence.
GO:0006816 calcium ion transport
NAS
PMID:3036867
Primary structure of the human 4F2 antigen heavy chain
REMOVE
Summary: This annotation references the original cloning paper from 1987. Early speculation about calcium transport was not confirmed. SLC3A2 functions as an amino acid transporter chaperone, not a calcium transporter.
Reason: No evidence supports calcium transport function for SLC3A2. This appears to be a legacy annotation from early characterization before the amino acid transport function was established. Modern structural and functional studies confirm amino acid transport exclusively.
Supporting Evidence:
PMID:3036867
Primary structure of the human 4F2 antigen heavy chain predicts a transmembrane protein with a cytoplasmic NH2 terminus.
GO:0006865 amino acid transport
TAS
PMID:10673541
Heterodimeric amino acid transporters: expression of heavy b...
ACCEPT
Summary: Review on heterodimeric amino acid transporters in placenta.
Reason: Core function.
Supporting Evidence:
PMID:10673541
Heterodimeric amino acid transporters: expression of heavy but not light chains of CD98 correlates with induction of amino acid transport systems in human placental trophoblast.
GO:0016020 membrane
NAS
PMID:3476959
Molecular cloning of complementary DNAs encoding the heavy c...
ACCEPT
Summary: Original cloning paper establishing membrane localization.
Reason: Valid core localization from foundational paper.
Supporting Evidence:
PMID:3476959
Molecular cloning of complementary DNAs encoding the heavy chain of the human 4F2 cell-surface antigen: a type II membrane glycoprotein involved in normal and neoplastic cell growth.
GO:0015327 cystine:glutamate antiporter activity
IDA
PMID:11417227
Identification and characterisation of human xCT that co-exp...
NEW
Summary: SLC3A2/4F2hc partners with xCT/SLC7A11 to form system xc-, the cystine/glutamate antiporter. The complex mediates Na+-independent exchange of extracellular cystine for intracellular glutamate (PMID:11417227, PMID:34880232). This is a core molecular function of the SLC3A2-xCT complex.
Reason: This core molecular function term was not present in existing GOA annotations but is well-supported by multiple experimental studies including the original characterization (PMID:11417227) and recent cryo-EM structures (PMID:34880232). System xc- activity is essential for cysteine homeostasis and ferroptosis regulation.
Supporting Evidence:
PMID:11417227
Identification and characterisation of human xCT that co-expresses, with 4F2 heavy chain, the amino acid transport activity system xc-.
PMID:34880232
Molecular basis for redox control by the human cystine/glutamate antiporter system xc().
GO:0006749 glutathione metabolic process
IMP
PMID:34880232
Molecular basis for redox control by the human cystine/gluta...
NEW
Summary: The xCT-4F2hc (system xc-) complex provides cystine for glutathione biosynthesis. Cystine is reduced to cysteine intracellularly, and cysteine is the rate-limiting substrate for glutathione synthesis. Inhibition of system xc- depletes cellular glutathione leading to ferroptosis.
Reason: SLC3A2 involvement in glutathione metabolism is well-established through its partnership with xCT for cystine import. This biological process is directly downstream of the cystine:glutamate antiporter activity.
Supporting Evidence:
PMID:34880232
Molecular basis for redox control by the human cystine/glutamate antiporter system xc().
GO:0097707 ferroptosis
IMP
PMID:34880232
Molecular basis for redox control by the human cystine/gluta...
NEW
Summary: Inhibition of the xCT-4F2hc (system xc-) complex leads to cystine starvation, glutathione depletion, and ferroptotic cell death characterized by iron-dependent lipid peroxidation. System xc- is a major target for inducing ferroptosis in cancer therapy.
Reason: SLC3A2 plays a critical regulatory role in ferroptosis through its partnership with xCT. Genetic or pharmacological inhibition of system xc- triggers ferroptosis, establishing SLC3A2 as involved in this cell death process.
Supporting Evidence:
PMID:34880232
Molecular basis for redox control by the human cystine/glutamate antiporter system xc().
GO:0031929 TOR signaling
NAS NEW
Summary: Added to align core_functions with existing annotations.
Reason: Core function term not present in existing_annotations.
Supporting Evidence:
PMID:9751058
Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family.
PMID:25998567
LAPTM4b recruits the LAT1-4F2hc Leu transporter to lysosomes and promotes mTORC1 activation.

Core Functions

SLC3A2/4F2hc forms obligate disulfide-linked heterodimers with SLC7 family light chain transporters (LAT1/SLC7A5, LAT2/SLC7A8, y+LAT1/SLC7A7, y+LAT2/SLC7A6, Asc-1/SLC7A10, xCT/SLC7A11). The heavy chain provides trafficking, plasma membrane localization, and stability for the light chains which provide the catalytic transport activity. Cryo-EM structures have elucidated the heterodimer architecture (PMID:30867591, PMID:33298890, PMID:34880232).

Supporting Evidence:
  • PMID:30867591
    Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex resolved at 3.3A resolution
  • PMID:34880232
    Molecular basis for redox control by the human cystine/glutamate antiporter system xc resolved by cryo-EM

The LAT1-4F2hc (SLC7A5-SLC3A2) complex mediates Na+-independent transport of large neutral amino acids, particularly leucine, which is critical for mTORC1 activation and cell growth. LAT2-4F2hc (SLC7A8-SLC3A2) also transports leucine with broader substrate specificity. This function is essential for nutrient sensing and cell proliferation.

Supporting Evidence:
  • PMID:9751058
    Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family established leucine as key substrate
  • PMID:25998567
    LAPTM4b recruits the LAT1-4F2hc Leu transporter to lysosomes for mTORC1 activation

The xCT-4F2hc (SLC7A11-SLC3A2) complex functions as system xc-, a cystine/glutamate antiporter that imports cystine in exchange for glutamate. This activity is essential for maintaining intracellular cysteine levels required for glutathione synthesis. The system xc- transporter is a critical regulator of ferroptosis - inhibition leads to iron-dependent lipid peroxidation and cell death (PMID:34880232, PMID:11417227).

Supporting Evidence:
  • PMID:11417227
    Identification and characterisation of human xCT that co-expresses, with 4F2 heavy chain, the amino acid transport activity system xc-
  • PMID:34880232
    Molecular basis for redox control by the human cystine/glutamate antiporter system xc structure and function

LAT1-4F2hc preferentially transports large neutral aromatic amino acids including phenylalanine, tyrosine, and tryptophan. This transport activity is Na+-independent and operates in exchange mode. LAT1 also transports thyroid hormones (T3, T4) which are structurally similar to tyrosine (PMID:11564694). LAT1 overexpression in tumors supports increased amino acid demand for cancer cell proliferation.

Supporting Evidence:
  • PMID:15589117
    LAT1-4F2hc aromatic amino acid transporter activity demonstrated with phenylalanine as substrate
  • PMID:11564694
    Thyroid hormone transport by the heterodimeric human system L amino acid transporter

References

Gene Ontology annotation through association of InterPro records with GO terms
Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity
Annotation inferences using phylogenetic trees
Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping
Gene Ontology annotation based on curation of immunofluorescence data
Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
Electronic Gene Ontology annotations created by ARBA machine learning models
Combined Automated Annotation using Multiple IEA Methods
Primary structure of the human 4F2 antigen heavy chain
  • Original cloning paper establishing SLC3A2 as a type II transmembrane glycoprotein
Molecular cloning of complementary DNAs encoding the heavy chain of the human 4F2 cell-surface antigen: a type II membrane glycoprotein involved in normal and neoplastic cell growth.
  • Foundational characterization of SLC3A2
Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family
  • Established that 4F2hc forms heterodimers with permease light chains for amino acid transport
Amino acid transport of y+L-type by heterodimers of 4F2hc/CD98
  • Characterized y+L amino acid transport by 4F2hc heterodimers
Identification of a membrane protein, LAT-2, that Co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids.
  • Discovery of LAT2/SLC7A8 as 4F2hc partner
LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter
  • Characterization of LAT2-4F2hc in kidney and intestine
The heterodimeric amino acid transporter 4F2hc/y+LAT2 mediates arginine efflux
  • Established y+LAT2/4F2hc arginine/glutamine exchange
Association of 4F2hc with light chains LAT1, LAT2 or y+LAT2 requires different domains
  • Domain mapping for light chain interactions
Identification and characterisation of human xCT that co-expresses, with 4F2 heavy chain, the amino acid transport activity system xc-.
  • Discovery of xCT/SLC7A11 as system xc- light chain partner of 4F2hc
  • Cystine/glutamate antiporter activity established
Human L-type amino acid transporter 1 (LAT1) characterization
  • Comprehensive LAT1-4F2hc functional characterization in tumor cells
Thyroid hormone transport by the heterodimeric human system L amino acid transporter
  • Demonstrated T3/T4 transport by system L
LAPTM4b recruits the LAT1-4F2hc Leu transporter to lysosomes
  • Lysosomal recruitment and mTORC1 activation mechanism
Hepatitis C Virus Modulates Solute carrier family 3 member 2 for Viral Propagation.
  • HCV exploits SLC3A2 for entry and mTORC1 activation
Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex
  • First cryo-EM structure of LAT1-4F2hc at 3.3A resolution
  • Revealed heterodimer architecture and disulfide linkage
Structural insight into the substrate recognition and transport mechanism of the human LAT2-4F2hc complex.
  • Cryo-EM structure of LAT2-4F2hc with substrates
Mechanism of substrate transport and inhibition of the human LAT1-4F2hc amino acid transporter.
  • Transport mechanism and inhibitor binding details
Plasmodium vivax binds host CD98hc (SLC3A2) to enter immature red blood cells.
  • SLC3A2 serves as malaria parasite receptor
Molecular basis for redox control by the human cystine/glutamate antiporter system xc
  • Cryo-EM structure of xCT/SLC7A11-4F2hc complex
  • Ferroptosis protection mechanism
Reactome:R-HSA-378513
SLC7A11-mediated exchange of extracellular cysteine and cytosolic glutamate
  • System xc- pathway annotation
Cloning and expression of a b(0,+)-like amino acid transporter functioning as a heterodimer with 4F2hc instead of rBAT. A new candidate gene for cystinuria.
Cloning and functional characterization of a Na(+)-independent, broad-specific neutral amino acid transporter from mammalian intestine.
Heterodimeric amino acid transporters: expression of heavy but not light chains of CD98 correlates with induction of amino acid transport systems in human placental trophoblast.
Identification and characterization of a Na(+)-independent neutral amino acid transporter that associates with the 4F2 heavy chain and exhibits substrate selectivity for small neutral D- and L-amino acids.
Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells.
Molecular cloning and characterization of CT120, a novel membrane-associated gene involved in amino acid transport and glutathione metabolism.
Human LAT1 single nucleotide polymorphism N230K does not alter phenylalanine transport.
Identification of stereoselective transporters for S-nitroso-L-cysteine: role of LAT1 and LAT2 in biological activity of S-nitrosothiols.
Ornithine transport via cationic amino acid transporter-1 is involved in ornithine cytotoxicity in retinal pigment epithelial cells.
Large-scale proteomics and phosphoproteomics of urinary exosomes.
Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT).
Quantitative proteomics identifies a Dab2/integrin module regulating cell migration.
Defining the membrane proteome of NK cells.
The pathogenic E. coli type III effector EspZ interacts with host CD98 and facilitates host cell prosurvival signalling.
MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis.
Raftlin is involved in the nucleocapture complex to induce poly(I:C)-mediated TLR3 activation.
Insights into RNA biology from an atlas of mammalian mRNA-binding proteins.
Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model.
In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.
KSHV attachment and entry are dependent on αVβ3 integrin localized to specific cell surface microdomains and do not correlate with the presence of heparan sulfate.
E-cadherin interactome complexity and robustness resolved by quantitative proteomics.
Impaired Amino Acid Transport at the Blood Brain Barrier Is a Cause of Autism Spectrum Disorder.
LC-MS/MS Based Quantitation of ABC and SLC Transporter Proteins in Plasma Membranes of Cultured Primary Human Retinal Pigment Epithelium Cells and Immortalized ARPE19 Cell Line.
Systematic protein-protein interaction mapping for clinically relevant human GPCRs.
Quantitative Protein Expression in the Human Retinal Pigment Epithelium: Comparison Between Apical and Basolateral Plasma Membranes With Emphasis on Transporters.
OpenCell: Endogenous tagging for the cartography of human cellular organization.
The solute carrier superfamily interactome.
Reactome:R-HSA-352191
SLC7A8-mediated uptake of neutral amino acids
Reactome:R-HSA-352232
SLC7A5:SLC3A2 transports neutral amino acids from extracellular region to cytosol
Reactome:R-HSA-375131
Basigin binds CD98 complex
Reactome:R-HSA-376200
SLC7A10-mediated uptake of small neutral amino acids
Reactome:R-HSA-379415
SLC7A7:SLC3A2 exchanges L-Arg for L-Leu, Na+ across the plasma membrane
Reactome:R-HSA-379426
SLC7A6 (y+LAT2)-mediated exchange of extracellular leucine for cytosolic arginine
Reactome:R-HSA-5660910
Defective SLC7A7 does not exchange L-Arg for L-Leu, Na+ across the plasma membrane
file:human/SLC3A2/SLC3A2-deep-research-falcon.md
Deep research report on SLC3A2

Tags

ferroptosis

šŸ“š Additional Documentation

Deep Research Falcon

(SLC3A2-deep-research-falcon.md)

provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2025-12-28T12:19:33.099745'
end_time: '2025-12-28T12:23:48.392423'
duration_seconds: 255.29
template_file: templates/gene_research_go_focused.md
template_variables:
organism: human
gene_id: SLC3A2
gene_symbol: SLC3A2
uniprot_accession: P08195
protein_description: 'RecName: Full=Amino acid transporter heavy chain SLC3A2 {ECO:0000305};
AltName: Full=4F2 cell-surface antigen heavy chain {ECO:0000303|PubMed:3476959};
Short=4F2hc {ECO:0000303|PubMed:11557028}; AltName: Full=4F2 heavy chain antigen
{ECO:0000303|PubMed:3036867}; AltName: Full=Lymphocyte activation antigen 4F2
large subunit {ECO:0000303|PubMed:3480538}; AltName: Full=Solute carrier family
3 member 2 {ECO:0000303|PubMed:12270127}; AltName: CD_antigen=CD98;'
gene_info: Name=SLC3A2 {ECO:0000312|HGNC:HGNC:11026}; Synonyms=MDU1;
organism_full: Homo sapiens (Human).
protein_family: Belongs to the SLC3A transporter family. .
protein_domains: Glyco_hydro_13_cat_dom. (IPR006047); Glyco_hydro_b. (IPR013780);
Glycoside_hydrolase_SF. (IPR017853); SLC3A2. (IPR042280); SLC3A2_N. (IPR031984)
provider_config:
timeout: 600
max_retries: 3
parameters:
allowed_domains: []
temperature: 0.1
citation_count: 19


Question

Gene Research for Functional Annotation

āš ļø CRITICAL: Gene/Protein Identification Context

BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

Target Gene/Protein Identity (from UniProt):

  • UniProt Accession: P08195
  • Protein Description: RecName: Full=Amino acid transporter heavy chain SLC3A2 {ECO:0000305}; AltName: Full=4F2 cell-surface antigen heavy chain {ECO:0000303|PubMed:3476959}; Short=4F2hc {ECO:0000303|PubMed:11557028}; AltName: Full=4F2 heavy chain antigen {ECO:0000303|PubMed:3036867}; AltName: Full=Lymphocyte activation antigen 4F2 large subunit {ECO:0000303|PubMed:3480538}; AltName: Full=Solute carrier family 3 member 2 {ECO:0000303|PubMed:12270127}; AltName: CD_antigen=CD98;
  • Gene Information: Name=SLC3A2 {ECO:0000312|HGNC:HGNC:11026}; Synonyms=MDU1;
  • Organism (full): Homo sapiens (Human).
  • Protein Family: Belongs to the SLC3A transporter family. .
  • Key Domains: Glyco_hydro_13_cat_dom. (IPR006047); Glyco_hydro_b. (IPR013780); Glycoside_hydrolase_SF. (IPR017853); SLC3A2. (IPR042280); SLC3A2_N. (IPR031984)

MANDATORY VERIFICATION STEPS:

  1. Check if the gene symbol "SLC3A2" matches the protein description above
  2. Verify the organism is correct: Homo sapiens (Human).
  3. Check if protein family/domains align with what you find in literature
  4. If you find literature for a DIFFERENT gene with the same or similar symbol, STOP

If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'SLC3A2' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

Research Target:

Please provide a comprehensive research report on the gene SLC3A2 (gene ID: SLC3A2, UniProt: P08195) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

Gene Research for Functional Annotation

āš ļø CRITICAL: Gene/Protein Identification Context

BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

Target Gene/Protein Identity (from UniProt):

  • UniProt Accession: P08195
  • Protein Description: RecName: Full=Amino acid transporter heavy chain SLC3A2 {ECO:0000305}; AltName: Full=4F2 cell-surface antigen heavy chain {ECO:0000303|PubMed:3476959}; Short=4F2hc {ECO:0000303|PubMed:11557028}; AltName: Full=4F2 heavy chain antigen {ECO:0000303|PubMed:3036867}; AltName: Full=Lymphocyte activation antigen 4F2 large subunit {ECO:0000303|PubMed:3480538}; AltName: Full=Solute carrier family 3 member 2 {ECO:0000303|PubMed:12270127}; AltName: CD_antigen=CD98;
  • Gene Information: Name=SLC3A2 {ECO:0000312|HGNC:HGNC:11026}; Synonyms=MDU1;
  • Organism (full): Homo sapiens (Human).
  • Protein Family: Belongs to the SLC3A transporter family. .
  • Key Domains: Glyco_hydro_13_cat_dom. (IPR006047); Glyco_hydro_b. (IPR013780); Glycoside_hydrolase_SF. (IPR017853); SLC3A2. (IPR042280); SLC3A2_N. (IPR031984)

MANDATORY VERIFICATION STEPS:

  1. Check if the gene symbol "SLC3A2" matches the protein description above
  2. Verify the organism is correct: Homo sapiens (Human).
  3. Check if protein family/domains align with what you find in literature
  4. If you find literature for a DIFFERENT gene with the same or similar symbol, STOP

If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'SLC3A2' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

Research Target:

Please provide a comprehensive research report on the gene SLC3A2 (gene ID: SLC3A2, UniProt: P08195) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Research plan verification and scope
- Identity and aliases: The human gene SLC3A2 encodes the type II transmembrane glycoprotein CD98 heavy chain (CD98hc; also known as 4F2hc/4F2 antigen), which is the ancillary (heavy) subunit of multiple heteromeric amino acid transporters (HATs). Authoritative 2024 reviews and structural studies consistently use these aliases and functions for human SLC3A2 (https://doi.org/10.14670/hh-18-749, Apr 2024; https://doi.org/10.1038/s41467-024-47948-4, May 2024). (park2024theroleof pages 2-3, wu2024thecompleteassembly pages 1-2, park2024theroleof pages 8-8, park2024theroleof pages 1-2)
- Organism: Homo sapiens is correct for the research summarized below (same sources as above). (park2024theroleof pages 2-3, wu2024thecompleteassembly pages 1-2)
- Domain/family note: Recent structural and biochemical literature define SLC3A2/CD98hc as a glycosylated type II membrane protein that forms disulfide-linked HATs with SLC7 light chains; there is no evidence that CD98hc is a glycoside hydrolase. Thus, any glycoside-hydrolase domain annotations are likely incongruent with current structural biology of SLC3A2. (wu2024thecompleteassembly pages 1-2, rullotubau2024structureandmechanisms pages 1-2)

1) Key concepts and definitions
- CD98hc/SLC3A2 is the heavy chain component of heteromeric amino acid transporters that covalently pair (via a conserved disulfide) with SLC7 family light chains to enable amino acid transport; CD98hc functions as an essential chaperone/scaffold required for light-chain trafficking and activity at the plasma membrane. It also associates with integrins and modulates outside-in signaling. 2024 reviews and structures reaffirm these roles (Park 2024 review, URL: https://doi.org/10.14670/hh-18-749; Wu et al., Nature Communications 2024, URL: https://doi.org/10.1038/s41467-024-47948-4). (park2024theroleof pages 2-3, wu2024thecompleteassembly pages 1-2, park2024theroleof pages 8-8, park2024theroleof pages 1-2)
- Canonical light-chain partners include LAT1 (SLC7A5) and LAT2 (SLC7A8), which mediate Na+-independent exchange of large neutral amino acids; additional partners include Asc-1 (SLC7A10) and others. 2024 cryo-EM of Asc-1/CD98hc further defines substrate specificity and transport mode for the Asc-1 complex. (https://doi.org/10.1038/s41467-024-47385-3, Apr 2024). (rullotubau2024structureandmechanisms pages 1-2, park2024theroleof pages 1-2)

2) Molecular function and substrate specificity
- LAT1–CD98hc (SLC7A5–SLC3A2) is a major route for essential large neutral amino acids (e.g., leucine, phenylalanine) and certain drugs; the complex is disulfide-linked (LAT1-C210 to CD98hc-C164) and its assembly and regulation involve specific lipids and post-translational modifications. Wu et al. (2024) demonstrate super-dimerization (LAT1–CD98hc)2, identify four bound phosphatidylethanolamine (PE) lipids at the LAT1 interface, and show regulation of LAT1 palmitoylation by CD98hc R183 impacting transport complex behavior (URL: https://doi.org/10.1038/s41467-024-47948-4, May 2024). (wu2024thecompleteassembly pages 1-2)
- Asc-1–CD98hc (SLC7A10–SLC3A2) uniquely supports facilitated diffusion of small neutral amino acids and efficiently transports glycine and D-serine (key NMDAR co-agonists), as resolved by cryo-EM structures (3.4–3.8 ƅ) and functional assays in 2024 (URL: https://doi.org/10.1038/s41467-024-47385-3, Apr 2024). Key residues Ser246 and Tyr333 in SLC7A10 determine substrate recognition and exchange versus facilitated-diffusion transport modes. (rullotubau2024structureandmechanisms pages 1-2)
- CD98hc acts as an essential ancillary subunit: it is not the catalytic transporter but is required for surface expression and stability of SLC7 light chains (review synthesis, URL: https://doi.org/10.14670/hh-18-749, Apr 2024). (park2024theroleof pages 2-3, park2024theroleof pages 8-8, park2024theroleof pages 1-2)

3) Subcellular localization and structural/biophysical features
- Localization: CD98hc-containing HATs are dynamically present at the plasma membrane and in lysosomes; Wu et al. (2024) validate the presence and assembly dynamics of LAT1–CD98hc at both locations, and show pH-sensitive super-dimerization influenced by N-glycans on CD98hc (URL: https://doi.org/10.1038/s41467-024-47948-4, May 2024). (wu2024thecompleteassembly pages 1-2)
- Disulfide linkage and glycosylation: CD98hc forms a conserved disulfide bond with SLC7 partners and is a glycosylated type II transmembrane glycoprotein; complex N-glycans modulate assembly and super-dimer behavior (Park 2024; Wu 2024). (https://doi.org/10.14670/hh-18-749; https://doi.org/10.1038/s41467-024-47948-4). (park2024theroleof pages 2-3, wu2024thecompleteassembly pages 1-2, park2024theroleof pages 1-2)
- Higher-order assembly and lipid regulation: Native MS and mass photometry demonstrate LAT1–CD98hc super-dimerization; four endogenous PE lipids stabilize interfaces and influence nearby LAT1 palmitoylation sites, linking membrane lipid composition and PTM cross-talk to transporter regulation (Wu 2024). (wu2024thecompleteassembly pages 1-2)

4) Signaling roles and pathway integration
- Integrin signaling: CD98hc directly associates with β integrins (e.g., β1/β3) and modulates adhesion-dependent signaling (FAK/PI3K-ERK/AKT), contributing to proliferation, survival, and oncogenic phenotypes in multiple models (reviewed in Park 2024). (https://doi.org/10.14670/hh-18-749). (park2024theroleof pages 2-3, park2024theroleof pages 8-8, park2024theroleof pages 1-2)
- Amino-acid sensing and mTORC1: By partnering with LAT1, CD98hc supports leucine uptake that feeds mTORC1 activation, coupling nutrient transport to growth signaling. The review synthesis highlights LAT1–CD98hc involvement in mTOR-linked tumor biology and therapeutic targeting (Park 2024). (https://doi.org/10.14670/hh-18-749). (park2024theroleof pages 2-3, park2024theroleof pages 1-2)

5) Disease relevance, applications, and real-world implementations
- Oncology biomarker and target: Elevated CD98hc expression is reported across several human cancers and is linked to malignant phenotypes and poor prognosis in multiple settings (Park 2024 overview, Apr 2024). (https://doi.org/10.14670/hh-18-749). (park2024theroleof pages 2-3, park2024theroleof pages 8-8, park2024theroleof pages 1-2)
- Antibody–drug conjugates (ADC): A 2023 preclinical study in colorectal cancer showed that an anti-CD98hc ADC recognizing the ectodomain internalizes to lysosomes, is potently cytotoxic to tumor cells, spares normal colon organoids, and suppresses tumor growth in xenograft and patient-derived xenograft models—supporting CD98hc as an actionable surface target (J Exp Clin Cancer Res, Aug 2023; URL: https://doi.org/10.1186/s13046-023-02784-0). (montero2023anaminoacid pages 1-2)

6) Recent developments and latest research (2023–2024)
- High-resolution structural advances (2024):
• LAT1–CD98hc complex: Super-dimerization, PE lipid binding, glycan modulation, and lysosomal/plasma membrane localization dynamics were defined by native MS, mass photometry, lipidomics, and mutagenesis (Nature Communications, May 2024; URL: https://doi.org/10.1038/s41467-024-47948-4). (wu2024thecompleteassembly pages 1-2)
• Asc-1–CD98hc complex: Cryo-EM structures clarified substrate binding determinants and the unique capacity for facilitated diffusion of glycine/D-serine (Nature Communications, Apr 2024; URL: https://doi.org/10.1038/s41467-024-47385-3). (rullotubau2024structureandmechanisms pages 1-2)
- Translational oncology (2023):
• Anti-CD98hc ADC in colorectal cancer advanced preclinical validation across cells, organoids, and PDXs, indicating a feasible therapeutic window (J Exp Clin Cancer Res, Aug 2023; URL: https://doi.org/10.1186/s13046-023-02784-0). (montero2023anaminoacid pages 1-2)
- Broad expert synthesis (2024):
• Park 2024 summarizes CD98hc’s integrated roles in amino acid transport complexes and integrin signaling, their links to mTOR and tumor progression, and therapeutic strategies (Histology and Histopathology, Apr 2024; URL: https://doi.org/10.14670/hh-18-749). (park2024theroleof pages 2-3, park2024theroleof pages 8-8, park2024theroleof pages 1-2)

7) Quantitative and clinical data (selected recent examples)
- CRC expression and ADC efficacy: Tumor-versus-normal analyses revealed significantly higher CD98hc expression in colorectal cancer tissues; the anti-CD98hc ADC showed strong anti-tumor activity in vitro and in vivo, with tumor organoids being sensitive and normal colon organoids largely spared (J Exp Clin Cancer Res, Aug 2023; URL: https://doi.org/10.1186/s13046-023-02784-0). (montero2023anaminoacid pages 1-2)
- Structural quantitation and mechanistic determinants: Native MS/mass photometry provide stoichiometric evidence for LAT1–CD98hc super-dimers, and lipidomics resolves bound PE lipids; mutational analyses pinpoint residues (e.g., CD98hc R183; LAT1 C187/C210) orchestrating lipid–PTM regulation and disulfide linkage (Nature Communications, May 2024; URL: https://doi.org/10.1038/s41467-024-47948-4). (wu2024thecompleteassembly pages 1-2)

Expert analysis and interpretation
- Converging structural and functional data establish SLC3A2/CD98hc as a central organizer of amino-acid transporter machineries and as an integrin-associated modulator of growth signaling. The 2024 structural studies move the field beyond a ā€œstatic chaperoneā€ model toward dynamic, lipid- and glycan-tuned assemblies that traffic between plasma membrane and lysosomes, providing new regulatory levers for pharmacology (e.g., interfering with super-dimerization or lipid/PTM cross-talk). In oncology, surface exposure, tumor-enriched expression, and efficient internalization underpin the rationale for anti-CD98hc ADCs; the 2023 CRC data demonstrate preclinical efficacy and selectivity needed for translation. Together, these insights support dual lines of translation: direct tumor targeting (e.g., ADCs) and indirect metabolic targeting via SLC7 partners (e.g., LAT1-directed strategies), with mTORC1 linkage providing pharmacodynamic readouts. (wu2024thecompleteassembly pages 1-2, montero2023anaminoacid pages 1-2, park2024theroleof pages 1-2)

References (URLs and dates)
- Park E et al. The role of CD98 heavy chain in cancer development. Histology and Histopathology. Apr 2024. URL: https://doi.org/10.14670/hh-18-749. (park2024theroleof pages 2-3, park2024theroleof pages 8-8, park2024theroleof pages 1-2)
- Wu D et al. The complete assembly of human LAT1-4F2hc complex provides insights into its regulation, function and localisation. Nature Communications. May 2024. URL: https://doi.org/10.1038/s41467-024-47948-4. (wu2024thecompleteassembly pages 1-2)
- Rullo-Tubau J et al. Structure and mechanisms of transport of human Asc1/CD98hc amino acid transporter. Nature Communications. Apr 2024. URL: https://doi.org/10.1038/s41467-024-47385-3. (rullotubau2024structureandmechanisms pages 1-2)
- Montero JC et al. An amino acid transporter subunit as an antibody–drug conjugate target in colorectal cancer. J Exp Clin Cancer Res. Aug 2023. URL: https://doi.org/10.1186/s13046-023-02784-0. (montero2023anaminoacid pages 1-2)

References

  1. (park2024theroleof pages 2-3): Eunsun Park, Hyesung Kim, Seokho Yoon, and B. Jang. The role of cd98 heavy chain in cancer development. Histology and histopathology, pages 18749, Apr 2024. URL: https://doi.org/10.14670/hh-18-749, doi:10.14670/hh-18-749. This article has 5 citations and is from a peer-reviewed journal.

  2. (wu2024thecompleteassembly pages 1-2): Di Wu, Renhong Yan, Siyuan Song, Andrew K. Swansiger, Yaning Li, James S. Prell, Qiang Zhou, and Carol V. Robinson. The complete assembly of human lat1-4f2hc complex provides insights into its regulation, function and localisation. Nature Communications, May 2024. URL: https://doi.org/10.1038/s41467-024-47948-4, doi:10.1038/s41467-024-47948-4. This article has 25 citations and is from a highest quality peer-reviewed journal.

  3. (park2024theroleof pages 8-8): Eunsun Park, Hyesung Kim, Seokho Yoon, and B. Jang. The role of cd98 heavy chain in cancer development. Histology and histopathology, pages 18749, Apr 2024. URL: https://doi.org/10.14670/hh-18-749, doi:10.14670/hh-18-749. This article has 5 citations and is from a peer-reviewed journal.

  4. (park2024theroleof pages 1-2): Eunsun Park, Hyesung Kim, Seokho Yoon, and B. Jang. The role of cd98 heavy chain in cancer development. Histology and histopathology, pages 18749, Apr 2024. URL: https://doi.org/10.14670/hh-18-749, doi:10.14670/hh-18-749. This article has 5 citations and is from a peer-reviewed journal.

  5. (rullotubau2024structureandmechanisms pages 1-2): Josep Rullo-Tubau, Maria Martinez-Molledo, Paola Bartoccioni, Ignasi Puch-Giner, Ɓngela Arias, Suwipa Saen-Oon, Camille Stephan-Otto Attolini, Rafael Artuch, Lucƭa Dƭaz, Vƭctor Guallar, Ekaitz Errasti-Murugarren, Manuel Palacƭn, and Oscar Llorca. Structure and mechanisms of transport of human asc1/cd98hc amino acid transporter. Nature Communications, Apr 2024. URL: https://doi.org/10.1038/s41467-024-47385-3, doi:10.1038/s41467-024-47385-3. This article has 10 citations and is from a highest quality peer-reviewed journal.

  6. (montero2023anaminoacid pages 1-2): Juan Carlos Montero, SofĆ­a del Carmen, Mar Abad, JosĆ© M. SayaguĆ©s, Antonio BarbĆ”chano, Asunción FernĆ”ndez-Barral, Alberto MuƱoz, and Atanasio Pandiella. An amino acid transporter subunit as an antibody–drug conjugate target in colorectal cancer. Journal of Experimental & Clinical Cancer Research : CR, Aug 2023. URL: https://doi.org/10.1186/s13046-023-02784-0, doi:10.1186/s13046-023-02784-0. This article has 8 citations.

Citations

  1. wu2024thecompleteassembly pages 1-2
  2. rullotubau2024structureandmechanisms pages 1-2
  3. montero2023anaminoacid pages 1-2
  4. park2024theroleof pages 2-3
  5. park2024theroleof pages 8-8
  6. park2024theroleof pages 1-2
  7. https://doi.org/10.14670/hh-18-749,
  8. https://doi.org/10.1038/s41467-024-47948-4,
  9. https://doi.org/10.14670/hh-18-749;
  10. https://doi.org/10.1038/s41467-024-47948-4
  11. https://doi.org/10.1038/s41467-024-47385-3,
  12. https://doi.org/10.14670/hh-18-749
  13. https://doi.org/10.1186/s13046-023-02784-0
  14. https://doi.org/10.1038/s41467-024-47385-3
  15. https://doi.org/10.14670/hh-18-749.
  16. https://doi.org/10.1038/s41467-024-47948-4.
  17. https://doi.org/10.1038/s41467-024-47385-3.
  18. https://doi.org/10.1186/s13046-023-02784-0.
  19. https://doi.org/10.1186/s13046-023-02784-0,

šŸ“„ View Raw YAML

id: P08195
gene_symbol: SLC3A2
product_type: PROTEIN
status: COMPLETE
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: 'SLC3A2 (also known as 4F2hc, CD98 heavy chain) encodes the essential heavy chain subunit of heteromeric amino acid transporters (HATs). It functions as a type II transmembrane glycoprotein that forms disulfide-linked heterodimers with various SLC7 family light chain transporters (SLC7A5/LAT1, SLC7A6/y+LAT2, SLC7A7/y+LAT1, SLC7A8/LAT2, SLC7A10/Asc-1, SLC7A11/xCT). SLC3A2 acts as a chaperone essential for the trafficking, plasma membrane localization, and stability of these light chain partners, which provide the actual catalytic transport activity. The SLC3A2/SLC7A5 (LAT1) complex mediates Na+-independent transport of large neutral amino acids (leucine, phenylalanine, tryptophan, tyrosine) and is critical for mTORC1 activation. The SLC3A2/SLC7A11 (xCT) complex functions as the cystine/glutamate antiporter system xc-, important for glutathione synthesis and protection against ferroptosis. SLC3A2 also modulates integrin signaling independently of its transport functions. High-resolution cryo-EM structures have elucidated the molecular architecture of these complexes.

  '
existing_annotations:
- term:
    id: GO:1903801
    label: L-leucine import across plasma membrane
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: 'SLC3A2 partners with LAT1 (SLC7A5) and LAT2 (SLC7A8) to form heterodimeric amino acid transporters that mediate leucine import. This is a core function well-supported by phylogenetic analysis and experimental evidence from multiple studies (PMID:9751058, PMID:10574970, PMID:11557028, PMID:30867591).

      '
    action: ACCEPT
    reason: 'L-leucine import is a well-established core function of SLC3A2-containing heterodimeric transporters. The IBA annotation is consistent with extensive experimental evidence.

      '
    supported_by:
    - reference_id: PMID:9751058
      supporting_text: Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family.
    - reference_id: PMID:30867591
      supporting_text: Mar 13. Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex.
    - reference_id: file:human/SLC3A2/SLC3A2-deep-research-falcon.md
      supporting_text: 'model: Edison Scientific Literature'
- term:
    id: GO:0015823
    label: phenylalanine transport
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: 'Phenylalanine is a well-established substrate for the LAT1-4F2hc and LAT2-4F2hc complexes. Multiple experimental studies confirm phenylalanine transport activity.

      '
    action: ACCEPT
    reason: 'Phenylalanine transport is a core function of SLC3A2-containing HAT complexes, supported by phylogenetic and experimental evidence.

      '
    supported_by:
    - reference_id: PMID:10574970
      supporting_text: LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine.
    - reference_id: PMID:11557028
      supporting_text: 'Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines.'
- term:
    id: GO:0016323
    label: basolateral plasma membrane
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: 'SLC3A2 localizes to both apical and basolateral plasma membranes in polarized epithelial cells. Basolateral localization is well-documented for kidney and intestinal epithelia where it partners with LAT2.

      '
    action: ACCEPT
    reason: 'Basolateral localization is supported by phylogenetic inference and consistent with experimental data from polarized epithelial cells (PMID:31791063).

      '
    supported_by:
    - reference_id: PMID:31791063
      supporting_text: 'Quantitative Protein Expression in the Human Retinal Pigment Epithelium: Comparison Between Apical and Basolateral Plasma Membranes With Emphasis on Transporters.'
- term:
    id: GO:0016324
    label: apical plasma membrane
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: 'SLC3A2 is found at the apical membrane of syncytiotrophoblasts and other polarized cells. Apical localization depends on the light chain partner.

      '
    action: ACCEPT
    reason: 'Apical localization is well-documented in multiple cell types and tissues.

      '
    supported_by:
    - reference_id: PMID:31791063
      supporting_text: 'Quantitative Protein Expression in the Human Retinal Pigment Epithelium: Comparison Between Apical and Basolateral Plasma Membranes With Emphasis on Transporters.'
- term:
    id: GO:1904273
    label: L-alanine import across plasma membrane
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: 'L-alanine transport is mediated by the LAT2-4F2hc complex. LAT2 has broader specificity for small and large neutral amino acids compared to LAT1.

      '
    action: ACCEPT
    reason: 'L-alanine import is established function of the SLC3A2/LAT2 complex based on experimental evidence (PMID:10391915).

      '
    supported_by:
    - reference_id: PMID:10391915
      supporting_text: Identification of a membrane protein, LAT-2, that Co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids.
- term:
    id: GO:0001618
    label: virus receptor activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: 'SLC3A2/CD98 has been demonstrated to act as a receptor for Plasmodium vivax entry into immature red blood cells (PMID:34294905) and facilitates hepatitis C virus entry (PMID:30341327). This represents a secondary function exploited by pathogens.

      '
    action: KEEP_AS_NON_CORE
    reason: 'While virus/pathogen receptor activity is experimentally validated, it represents exploitation of SLC3A2 by pathogens rather than a core physiological function.

      '
    supported_by:
    - reference_id: PMID:34294905
      supporting_text: 2021 Jul 22. Plasmodium vivax binds host CD98hc (SLC3A2) to enter immature red blood cells.
    - reference_id: PMID:30341327
      supporting_text: Hepatitis C Virus Modulates Solute carrier family 3 member 2 for Viral Propagation.
- term:
    id: GO:0005765
    label: lysosomal membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: 'SLC3A2 is recruited to lysosomes by LAPTM4B where the LAT1-4F2hc complex promotes leucine uptake into lysosomes, facilitating mTORC1 activation (PMID:25998567).

      '
    action: ACCEPT
    reason: 'Lysosomal localization is experimentally verified and functionally important for mTORC1 signaling.

      '
    supported_by:
    - reference_id: PMID:25998567
      supporting_text: LAPTM4b recruits the LAT1-4F2hc Leu transporter to lysosomes and promotes mTORC1 activation.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: 'Plasma membrane localization is the primary site of SLC3A2 function where it forms heterodimeric transporters. Extensively validated by experimental studies and structural biology.

      '
    action: ACCEPT
    reason: 'Core localization supported by cryo-EM structures and numerous functional studies.

      '
    supported_by:
    - reference_id: PMID:30867591
      supporting_text: Mar 13. Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex.
- term:
    id: GO:0005975
    label: carbohydrate metabolic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: 'This annotation is based on the glycoside hydrolase domain annotation in InterPro. However, SLC3A2 does NOT function as a glycoside hydrolase - it functions as an amino acid transporter chaperone. The alpha-amylase-like fold is structural but not catalytically active. This is an erroneous electronic annotation.

      '
    action: REMOVE
    reason: 'SLC3A2 does not participate in carbohydrate metabolism. While it contains an alpha-amylase-like domain fold, this domain has been repurposed for structural roles in membrane association and heterodimer formation, not carbohydrate hydrolysis. Recent structural studies (PMID:30867591, PMID:33298890) confirm this domain mediates protein-protein interactions, not enzymatic activity.

      '
    supported_by:
    - reference_id: PMID:30867591
      supporting_text: Mar 13. Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex.
- term:
    id: GO:0006865
    label: amino acid transport
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: 'Amino acid transport is the primary function of SLC3A2 when complexed with SLC7 family light chains. This is a core function.

      '
    action: ACCEPT
    reason: 'Core function well-established by extensive experimental evidence.

      '
- term:
    id: GO:0015823
    label: phenylalanine transport
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  review:
    summary: 'Duplicate of IBA annotation above. Phenylalanine transport is a well-established substrate for LAT1 and LAT2 complexes with SLC3A2.

      '
    action: ACCEPT
    reason: 'Core function - phenylalanine is a well-characterized substrate.

      '
- term:
    id: GO:0015827
    label: tryptophan transport
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  review:
    summary: 'Tryptophan is a substrate for LAT1-4F2hc and LAT2-4F2hc complexes. Experimentally verified in multiple studies.

      '
    action: ACCEPT
    reason: 'Core function supported by experimental evidence (PMID:10574970, PMID:11557028, PMID:11564694).

      '
    supported_by:
    - reference_id: PMID:10574970
      supporting_text: LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine.
- term:
    id: GO:0016020
    label: membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  review:
    summary: 'Generic membrane annotation. SLC3A2 is a type II transmembrane protein - more specific annotations (plasma membrane, lysosomal membrane) are also present.

      '
    action: ACCEPT
    reason: 'Valid but general annotation. More specific CC annotations are preferable.

      '
- term:
    id: GO:0016323
    label: basolateral plasma membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: 'Duplicate of IBA annotation. Valid localization for SLC3A2 in polarized epithelial cells.

      '
    action: ACCEPT
    reason: 'Well-supported localization.

      '
- term:
    id: GO:0016324
    label: apical plasma membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: 'Duplicate of IBA annotation. Valid localization.

      '
    action: ACCEPT
    reason: 'Well-supported localization in polarized cells.

      '
- term:
    id: GO:0042470
    label: melanosome
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: 'SLC3A2 was identified in melanosome proteomics studies. This likely reflects amino acid transporter activity in these specialized organelles.

      '
    action: KEEP_AS_NON_CORE
    reason: 'Melanosome localization is based on proteomics data but not a core localization.

      '
- term:
    id: GO:0046982
    label: protein heterodimerization activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  review:
    summary: 'Heterodimerization with SLC7 family members is THE core molecular function of SLC3A2. It forms obligate disulfide-linked heterodimers with light chains.

      '
    action: ACCEPT
    reason: 'Core molecular function. SLC3A2 forms heterodimers with at least 6 different SLC7 family members (SLC7A5, SLC7A6, SLC7A7, SLC7A8, SLC7A10, SLC7A11).

      '
    supported_by:
    - reference_id: PMID:30867591
      supporting_text: Mar 13. Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex.
    - reference_id: PMID:34880232
      supporting_text: Molecular basis for redox control by the human cystine/glutamate antiporter system xc().
- term:
    id: GO:0070161
    label: anchoring junction
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: 'SLC3A2 localizes to cell-cell adhesion sites and interacts with integrins. This relates to its integrin signaling modulation function.

      '
    action: KEEP_AS_NON_CORE
    reason: 'Junction localization is secondary to its transport function.

      '
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:20374249
  review:
    summary: 'This annotation is based on interaction with E. coli EspZ effector protein. Represents pathogen exploitation of SLC3A2.

      '
    action: MARK_AS_OVER_ANNOTATED
    reason: 'Generic protein binding annotation - more specific MF terms exist for the relevant interactions (heterodimerization with SLC7 proteins).

      '
    supported_by:
    - reference_id: PMID:20374249
      supporting_text: The pathogenic E. coli type III effector EspZ interacts with host CD98 and facilitates host cell prosurvival signalling.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:28298427
  review:
    summary: 'Interaction with GPR37. Represents a GPCR interaction study.

      '
    action: MARK_AS_OVER_ANNOTATED
    reason: 'Generic protein binding - should be replaced with more specific term if functional significance is established.

      '
    supported_by:
    - reference_id: PMID:28298427
      supporting_text: Systematic protein-protein interaction mapping for clinically relevant human GPCRs.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:30867591
  review:
    summary: 'Structural study demonstrating interaction with SLC7A5/LAT1.

      '
    action: MODIFY
    reason: 'This is heterodimerization with SLC7A5 - should use GO:0046982 protein heterodimerization activity, which is also present.

      '
    proposed_replacement_terms:
    - id: GO:0046982
      label: protein heterodimerization activity
    supported_by:
    - reference_id: PMID:30867591
      supporting_text: Mar 13. Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:34880232
  review:
    summary: 'Structural study of xCT/SLC7A11 interaction with SLC3A2.

      '
    action: MODIFY
    reason: 'This is heterodimerization - more specific term exists.

      '
    proposed_replacement_terms:
    - id: GO:0046982
      label: protein heterodimerization activity
    supported_by:
    - reference_id: PMID:34880232
      supporting_text: Molecular basis for redox control by the human cystine/glutamate antiporter system xc().
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:35271311
  review:
    summary: 'OpenCell high-throughput study detecting LAT1 interaction.

      '
    action: MARK_AS_OVER_ANNOTATED
    reason: 'Generic protein binding from HT study - heterodimerization terms are more informative.

      '
    supported_by:
    - reference_id: PMID:35271311
      supporting_text: '2022 Mar 11. OpenCell: Endogenous tagging for the cartography of human cellular organization.'
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:40355756
  review:
    summary: 'SLC transporter interactome study.

      '
    action: MARK_AS_OVER_ANNOTATED
    reason: 'Generic protein binding - specific interactions should use more specific terms.

      '
    supported_by:
    - reference_id: PMID:40355756
      supporting_text: 2025 May 12. The solute carrier superfamily interactome.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:9878049
  review:
    summary: 'Early study establishing y+LAT interaction with 4F2hc.

      '
    action: MODIFY
    reason: 'This demonstrates heterodimerization with SLC7A7.

      '
    proposed_replacement_terms:
    - id: GO:0046982
      label: protein heterodimerization activity
    supported_by:
    - reference_id: PMID:9878049
      supporting_text: Amino acid transport of y+L-type by heterodimers of 4F2hc/CD98 and members of the glycoprotein-associated amino acid transporter family.
- term:
    id: GO:0015820
    label: L-leucine transport
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: 'Leucine transport is a core function of SLC3A2-containing complexes, especially LAT1-4F2hc. Critical for mTORC1 signaling.

      '
    action: ACCEPT
    reason: 'Well-established core function.

      '
- term:
    id: GO:0042803
    label: protein homodimerization activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: 'Crystal structure of the SLC3A2 ectodomain (PMID:17724034) shows it can form homodimers, though heterodimer formation with SLC7 proteins is its primary functional form.

      '
    action: KEEP_AS_NON_CORE
    reason: 'Homodimerization has been structurally observed but heterodimerization with SLC7 light chains is the functional form.

      '
    supported_by:
    - reference_id: PMID:17724034
- term:
    id: GO:0043025
    label: neuronal cell body
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: 'Neuronal localization transferred from mouse ortholog. SLC3A2/LAT1 is expressed in neurons and at the blood-brain barrier.

      '
    action: ACCEPT
    reason: 'Neuronal expression is well-documented for amino acid transport functions.

      '
- term:
    id: GO:0044225
    label: apical pole of neuron
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: 'Specific neuronal localization from ortholog transfer.

      '
    action: KEEP_AS_NON_CORE
    reason: 'Valid but cell-type specific localization.

      '
- term:
    id: GO:0045202
    label: synapse
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: 'Synaptic localization likely reflects amino acid transporter function at synapses. Asc-1/CD98hc transports D-serine and glycine, key NMDAR co-agonists.

      '
    action: KEEP_AS_NON_CORE
    reason: 'Synaptic localization is relevant for neuromodulator transport.

      '
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: IDA
  original_reference_id: GO_REF:0000052
  review:
    summary: 'HPA immunofluorescence data confirming plasma membrane localization.

      '
    action: ACCEPT
    reason: 'Core localization validated by immunofluorescence.

      '
- term:
    id: GO:0089718
    label: amino acid import across plasma membrane
  evidence_type: NAS
  original_reference_id: PMID:10734121
  review:
    summary: 'Small neutral amino acid transporter asc-2/SLC7A10 association with 4F2hc for amino acid import.

      '
    action: ACCEPT
    reason: 'Amino acid import is a core function of SLC3A2-containing transporters.

      '
    supported_by:
    - reference_id: PMID:10734121
      supporting_text: Identification and characterization of a Na(+)-independent neutral amino acid transporter that associates with the 4F2 heavy chain and exhibits substrate selectivity for small neutral D- and L-amino acids.
- term:
    id: GO:0089718
    label: amino acid import across plasma membrane
  evidence_type: IDA
  original_reference_id: PMID:10903140
  review:
    summary: 'Demonstrates arginine efflux in exchange with glutamine via y+LAT2/4F2hc.

      '
    action: ACCEPT
    reason: 'Core function - amino acid exchange across plasma membrane.

      '
    supported_by:
    - reference_id: PMID:10903140
      supporting_text: The heterodimeric amino acid transporter 4F2hc/y+LAT2 mediates arginine efflux in exchange with glutamine.
- term:
    id: GO:0089718
    label: amino acid import across plasma membrane
  evidence_type: IDA
  original_reference_id: PMID:11417227
  review:
    summary: 'Key paper identifying xCT/SLC7A11 as the partner of 4F2hc for system xc- activity (cystine/glutamate antiporter). Cystine import is critical.

      '
    action: ACCEPT
    reason: 'Core function - cystine import is essential for glutathione synthesis.

      '
    supported_by:
    - reference_id: PMID:11417227
      supporting_text: Identification and characterisation of human xCT that co-expresses, with 4F2 heavy chain, the amino acid transport activity system xc-.
- term:
    id: GO:0089718
    label: amino acid import across plasma membrane
  evidence_type: IDA
  original_reference_id: PMID:30867591
  review:
    summary: 'Cryo-EM structure of LAT1-4F2hc complex with functional characterization.

      '
    action: ACCEPT
    reason: 'Core function supported by structural and functional studies.

      '
    supported_by:
    - reference_id: PMID:30867591
      supporting_text: Mar 13. Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex.
- term:
    id: GO:0089718
    label: amino acid import across plasma membrane
  evidence_type: IDA
  original_reference_id: PMID:33758168
  review:
    summary: 'Mechanism of substrate transport and inhibition of LAT1-4F2hc.

      '
    action: ACCEPT
    reason: 'Core function with mechanistic detail.

      '
    supported_by:
    - reference_id: PMID:33758168
      supporting_text: Mechanism of substrate transport and inhibition of the human LAT1-4F2hc amino acid transporter.
- term:
    id: GO:0089718
    label: amino acid import across plasma membrane
  evidence_type: IDA
  original_reference_id: PMID:9878049
  review:
    summary: 'Early characterization of y+L-type transport by 4F2hc heterodimers.

      '
    action: ACCEPT
    reason: 'Foundational paper establishing amino acid transport function.

      '
    supported_by:
    - reference_id: PMID:9878049
      supporting_text: Amino acid transport of y+L-type by heterodimers of 4F2hc/CD98 and members of the glycoprotein-associated amino acid transporter family.
- term:
    id: GO:0150104
    label: transport across blood-brain barrier
  evidence_type: NAS
  original_reference_id: PMID:27912058
  review:
    summary: 'LAT1-4F2hc at the blood-brain barrier transports essential amino acids. Impaired transport is linked to autism spectrum disorder.

      '
    action: KEEP_AS_NON_CORE
    reason: 'Tissue-specific function reflecting amino acid transport at BBB.

      '
    supported_by:
    - reference_id: PMID:27912058
      supporting_text: Impaired Amino Acid Transport at the Blood Brain Barrier Is a Cause of Autism Spectrum Disorder.
- term:
    id: GO:0046982
    label: protein heterodimerization activity
  evidence_type: IDA
  original_reference_id: PMID:33298890
  review:
    summary: 'Cryo-EM structure of LAT2-4F2hc complex demonstrating heterodimer architecture.

      '
    action: ACCEPT
    reason: 'Core molecular function directly demonstrated by structural biology.

      '
    supported_by:
    - reference_id: PMID:33298890
      supporting_text: Structural insight into the substrate recognition and transport mechanism of the human LAT2-4F2hc complex.
- term:
    id: GO:0140272
    label: exogenous protein binding
  evidence_type: IDA
  original_reference_id: PMID:30341327
  review:
    summary: 'Binding to hepatitis C virus envelope proteins facilitating viral entry.

      '
    action: KEEP_AS_NON_CORE
    reason: 'Pathogen exploitation of SLC3A2 - not a core function.

      '
    supported_by:
    - reference_id: PMID:30341327
      supporting_text: Hepatitis C Virus Modulates Solute carrier family 3 member 2 for Viral Propagation.
- term:
    id: GO:0140272
    label: exogenous protein binding
  evidence_type: IDA
  original_reference_id: PMID:34294905
  review:
    summary: 'CD98hc serves as a receptor for Plasmodium vivax entry into reticulocytes.

      '
    action: KEEP_AS_NON_CORE
    reason: 'Pathogen receptor function - exploited by malaria parasite.

      '
    supported_by:
    - reference_id: PMID:34294905
      supporting_text: 2021 Jul 22. Plasmodium vivax binds host CD98hc (SLC3A2) to enter immature red blood cells.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:33298890
  review:
    summary: 'Interaction with SLC7A8/LAT2 demonstrated structurally.

      '
    action: MODIFY
    reason: 'Heterodimerization - more specific term available.

      '
    proposed_replacement_terms:
    - id: GO:0046982
      label: protein heterodimerization activity
    supported_by:
    - reference_id: PMID:33298890
      supporting_text: Structural insight into the substrate recognition and transport mechanism of the human LAT2-4F2hc complex.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: IDA
  original_reference_id: PMID:11311135
  review:
    summary: 'Study showing domain requirements for 4F2hc association with LAT1, LAT2, y+LAT2.

      '
    action: ACCEPT
    reason: 'Well-established core localization.

      '
    supported_by:
    - reference_id: PMID:11311135
      supporting_text: Association of 4F2hc with light chains LAT1, LAT2 or y+LAT2 requires different domains.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: IDA
  original_reference_id: PMID:11557028
  review:
    summary: 'LAT1 characterization showing plasma membrane localization.

      '
    action: ACCEPT
    reason: 'Core localization.

      '
    supported_by:
    - reference_id: PMID:11557028
      supporting_text: 'Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines.'
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: IDA
  original_reference_id: PMID:12225859
  review:
    summary: 'System L amino acid transporter in T24 bladder carcinoma cells.

      '
    action: ACCEPT
    reason: 'Core localization.

      '
    supported_by:
    - reference_id: PMID:12225859
      supporting_text: Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells.
- term:
    id: GO:0015818
    label: isoleucine transport
  evidence_type: IDA
  original_reference_id: PMID:11311135
  review:
    summary: 'Isoleucine is transported by LAT1-4F2hc and LAT2-4F2hc complexes.

      '
    action: ACCEPT
    reason: 'Core function - isoleucine is a branched-chain amino acid substrate.

      '
    supported_by:
    - reference_id: PMID:11311135
      supporting_text: Association of 4F2hc with light chains LAT1, LAT2 or y+LAT2 requires different domains.
- term:
    id: GO:0015818
    label: isoleucine transport
  evidence_type: IDA
  original_reference_id: PMID:11557028
  review:
    summary: 'LAT1 characterization showing isoleucine transport.

      '
    action: ACCEPT
    reason: 'Core function.

      '
    supported_by:
    - reference_id: PMID:11557028
      supporting_text: 'Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines.'
- term:
    id: GO:0015820
    label: L-leucine transport
  evidence_type: IDA
  original_reference_id: PMID:10574970
  review:
    summary: 'LAT2 characterization showing leucine transport.

      '
    action: ACCEPT
    reason: 'Core function - leucine is essential for mTORC1 signaling.

      '
    supported_by:
    - reference_id: PMID:10574970
      supporting_text: LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine.
- term:
    id: GO:0015820
    label: L-leucine transport
  evidence_type: IDA
  original_reference_id: PMID:11557028
  review:
    summary: 'LAT1 characterization in tumor cells.

      '
    action: ACCEPT
    reason: 'Core function.

      '
    supported_by:
    - reference_id: PMID:11557028
      supporting_text: 'Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines.'
- term:
    id: GO:0015820
    label: L-leucine transport
  evidence_type: IDA
  original_reference_id: PMID:11564694
  review:
    summary: 'System L transporter characterization.

      '
    action: ACCEPT
    reason: 'Core function.

      '
    supported_by:
    - reference_id: PMID:11564694
      supporting_text: Thyroid hormone transport by the heterodimeric human system L amino acid transporter.
- term:
    id: GO:0015820
    label: L-leucine transport
  evidence_type: IDA
  original_reference_id: PMID:12225859
  review:
    summary: 'T24 bladder carcinoma cell characterization.

      '
    action: ACCEPT
    reason: 'Core function.

      '
    supported_by:
    - reference_id: PMID:12225859
      supporting_text: Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells.
- term:
    id: GO:0015820
    label: L-leucine transport
  evidence_type: IDA
  original_reference_id: PMID:15769744
  review:
    summary: 'S-nitroso-L-cysteine transport via LAT1/LAT2.

      '
    action: ACCEPT
    reason: 'Core function with additional substrate discovery.

      '
    supported_by:
    - reference_id: PMID:15769744
      supporting_text: '2005 Mar 15. Identification of stereoselective transporters for S-nitroso-L-cysteine: role of LAT1 and LAT2 in biological activity of S-nitrosothiols.'
- term:
    id: GO:0015820
    label: L-leucine transport
  evidence_type: IDA
  original_reference_id: PMID:9751058
  review:
    summary: 'Foundational paper establishing 4F2hc permease heterodimer transport.

      '
    action: ACCEPT
    reason: 'Core function - seminal paper.

      '
    supported_by:
    - reference_id: PMID:9751058
      supporting_text: Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family.
- term:
    id: GO:0015821
    label: methionine transport
  evidence_type: IDA
  original_reference_id: PMID:11557028
  review:
    summary: 'LAT1 transports methionine, which is important for methylation reactions.

      '
    action: ACCEPT
    reason: 'Core function.

      '
    supported_by:
    - reference_id: PMID:11557028
      supporting_text: 'Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines.'
- term:
    id: GO:0015823
    label: phenylalanine transport
  evidence_type: IDA
  original_reference_id: PMID:10574970
  review:
    summary: 'LAT2 phenylalanine transport characterization.

      '
    action: ACCEPT
    reason: 'Core function.

      '
    supported_by:
    - reference_id: PMID:10574970
      supporting_text: LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine.
- term:
    id: GO:0015823
    label: phenylalanine transport
  evidence_type: IDA
  original_reference_id: PMID:11557028
  review:
    summary: 'LAT1 phenylalanine transport.

      '
    action: ACCEPT
    reason: 'Core function.

      '
    supported_by:
    - reference_id: PMID:11557028
      supporting_text: 'Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines.'
- term:
    id: GO:0015823
    label: phenylalanine transport
  evidence_type: IDA
  original_reference_id: PMID:11564694
  review:
    summary: 'System L transporter phenylalanine transport.

      '
    action: ACCEPT
    reason: 'Core function.

      '
    supported_by:
    - reference_id: PMID:11564694
      supporting_text: Thyroid hormone transport by the heterodimeric human system L amino acid transporter.
- term:
    id: GO:0015823
    label: phenylalanine transport
  evidence_type: IDA
  original_reference_id: PMID:9751058
  review:
    summary: 'Foundational study on 4F2hc heterodimer transport.

      '
    action: ACCEPT
    reason: 'Core function.

      '
    supported_by:
    - reference_id: PMID:9751058
      supporting_text: Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family.
- term:
    id: GO:0015824
    label: proline transport
  evidence_type: IDA
  original_reference_id: PMID:10574970
  review:
    summary: 'Proline transport by LAT2-4F2hc.

      '
    action: ACCEPT
    reason: 'LAT2 has broader substrate specificity including proline.

      '
    supported_by:
    - reference_id: PMID:10574970
      supporting_text: LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine.
- term:
    id: GO:0015827
    label: tryptophan transport
  evidence_type: IDA
  original_reference_id: PMID:10574970
  review:
    summary: 'Tryptophan transport by LAT2.

      '
    action: ACCEPT
    reason: 'Core function.

      '
    supported_by:
    - reference_id: PMID:10574970
      supporting_text: LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine.
- term:
    id: GO:0015827
    label: tryptophan transport
  evidence_type: IDA
  original_reference_id: PMID:11557028
  review:
    summary: 'Tryptophan transport by LAT1.

      '
    action: ACCEPT
    reason: 'Core function - large neutral aromatic amino acid.

      '
    supported_by:
    - reference_id: PMID:11557028
      supporting_text: 'Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines.'
- term:
    id: GO:0015827
    label: tryptophan transport
  evidence_type: IDA
  original_reference_id: PMID:11564694
  review:
    summary: 'System L tryptophan transport.

      '
    action: ACCEPT
    reason: 'Core function.

      '
    supported_by:
    - reference_id: PMID:11564694
      supporting_text: Thyroid hormone transport by the heterodimeric human system L amino acid transporter.
- term:
    id: GO:0015828
    label: tyrosine transport
  evidence_type: IDA
  original_reference_id: PMID:11557028
  review:
    summary: 'Tyrosine transport by LAT1.

      '
    action: ACCEPT
    reason: 'Core function - aromatic amino acid.

      '
    supported_by:
    - reference_id: PMID:11557028
      supporting_text: 'Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines.'
- term:
    id: GO:0015828
    label: tyrosine transport
  evidence_type: IDA
  original_reference_id: PMID:11564694
  review:
    summary: 'System L tyrosine transport.

      '
    action: ACCEPT
    reason: 'Core function.

      '
    supported_by:
    - reference_id: PMID:11564694
      supporting_text: Thyroid hormone transport by the heterodimeric human system L amino acid transporter.
- term:
    id: GO:0015829
    label: valine transport
  evidence_type: IDA
  original_reference_id: PMID:11557028
  review:
    summary: 'Valine transport by LAT1.

      '
    action: ACCEPT
    reason: 'Core function - branched-chain amino acid.

      '
    supported_by:
    - reference_id: PMID:11557028
      supporting_text: 'Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines.'
- term:
    id: GO:0070327
    label: thyroid hormone transport
  evidence_type: IDA
  original_reference_id: PMID:11564694
  review:
    summary: 'LAT1 and LAT2 transport thyroid hormones (T3, T4) which structurally resemble tyrosine.

      '
    action: KEEP_AS_NON_CORE
    reason: 'Valid function but secondary to amino acid transport - thyroid hormones are structurally similar to tyrosine.

      '
    supported_by:
    - reference_id: PMID:11564694
      supporting_text: Thyroid hormone transport by the heterodimeric human system L amino acid transporter.
- term:
    id: GO:1902024
    label: L-histidine transport
  evidence_type: IDA
  original_reference_id: PMID:11557028
  review:
    summary: 'Histidine transport by LAT1.

      '
    action: ACCEPT
    reason: 'Core function.

      '
    supported_by:
    - reference_id: PMID:11557028
      supporting_text: 'Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines.'
- term:
    id: GO:1902024
    label: L-histidine transport
  evidence_type: IDA
  original_reference_id: PMID:9751058
  review:
    summary: 'Histidine transport by 4F2hc heterodimers.

      '
    action: ACCEPT
    reason: 'Core function.

      '
    supported_by:
    - reference_id: PMID:9751058
      supporting_text: Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:30341327
  review:
    summary: 'Interaction with HCV E2 envelope protein.

      '
    action: KEEP_AS_NON_CORE
    reason: 'Pathogen interaction - exogenous protein binding term more appropriate.

      '
    supported_by:
    - reference_id: PMID:30341327
      supporting_text: Hepatitis C Virus Modulates Solute carrier family 3 member 2 for Viral Propagation.
- term:
    id: GO:0015820
    label: L-leucine transport
  evidence_type: IMP
  original_reference_id: PMID:30341327
  review:
    summary: 'Leucine transport enhanced during HCV infection promoting mTORC1 signaling.

      '
    action: ACCEPT
    reason: 'Core function demonstrated by mutant phenotype.

      '
    supported_by:
    - reference_id: PMID:30341327
      supporting_text: Hepatitis C Virus Modulates Solute carrier family 3 member 2 for Viral Propagation.
- term:
    id: GO:0046718
    label: symbiont entry into host cell
  evidence_type: IMP
  original_reference_id: PMID:30341327
  review:
    summary: 'SLC3A2 facilitates HCV entry into host cells.

      '
    action: KEEP_AS_NON_CORE
    reason: 'Pathogen exploitation function - not a normal physiological role.

      '
    supported_by:
    - reference_id: PMID:30341327
      supporting_text: Hepatitis C Virus Modulates Solute carrier family 3 member 2 for Viral Propagation.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: IDA
  original_reference_id: PMID:28112518
  review:
    summary: 'Mass spectrometry quantitation in retinal pigment epithelial cells.

      '
    action: ACCEPT
    reason: 'Core localization.

      '
    supported_by:
    - reference_id: PMID:28112518
      supporting_text: Epub 2017 Feb 14. LC-MS/MS Based Quantitation of ABC and SLC Transporter Proteins in Plasma Membranes of Cultured Primary Human Retinal Pigment Epithelium Cells and Immortalized ARPE19 Cell Line.
- term:
    id: GO:0015180
    label: L-alanine transmembrane transporter activity
  evidence_type: IGI
  original_reference_id: PMID:10391915
  review:
    summary: 'LAT2-4F2hc complex transports alanine - shown by co-expression with SLC7A8.

      '
    action: ACCEPT
    reason: 'Core molecular function demonstrated by genetic interaction.

      '
    supported_by:
    - reference_id: PMID:10391915
      supporting_text: Identification of a membrane protein, LAT-2, that Co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids.
- term:
    id: GO:0015190
    label: L-leucine transmembrane transporter activity
  evidence_type: IGI
  original_reference_id: PMID:10391915
  review:
    summary: 'LAT2-4F2hc leucine transporter activity.

      '
    action: ACCEPT
    reason: 'Core molecular function.

      '
    supported_by:
    - reference_id: PMID:10391915
      supporting_text: Identification of a membrane protein, LAT-2, that Co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids.
- term:
    id: GO:1903801
    label: L-leucine import across plasma membrane
  evidence_type: IGI
  original_reference_id: PMID:10391915
  review:
    summary: 'Leucine import by LAT2-4F2hc.

      '
    action: ACCEPT
    reason: 'Core function.

      '
    supported_by:
    - reference_id: PMID:10391915
      supporting_text: Identification of a membrane protein, LAT-2, that Co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids.
- term:
    id: GO:1904273
    label: L-alanine import across plasma membrane
  evidence_type: IGI
  original_reference_id: PMID:10391915
  review:
    summary: 'Alanine import by LAT2-4F2hc.

      '
    action: ACCEPT
    reason: 'Core function.

      '
    supported_by:
    - reference_id: PMID:10391915
      supporting_text: Identification of a membrane protein, LAT-2, that Co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids.
- term:
    id: GO:0009925
    label: basal plasma membrane
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: 'Basal membrane localization inferred from sequence similarity.

      '
    action: ACCEPT
    reason: 'Valid localization consistent with basolateral distribution.

      '
- term:
    id: GO:0016323
    label: basolateral plasma membrane
  evidence_type: IDA
  original_reference_id: PMID:31791063
  review:
    summary: 'Direct experimental evidence for basolateral localization in RPE cells.

      '
    action: ACCEPT
    reason: 'Core localization validated experimentally.

      '
    supported_by:
    - reference_id: PMID:31791063
      supporting_text: 'Quantitative Protein Expression in the Human Retinal Pigment Epithelium: Comparison Between Apical and Basolateral Plasma Membranes With Emphasis on Transporters.'
- term:
    id: GO:0016324
    label: apical plasma membrane
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: 'Apical localization from sequence similarity.

      '
    action: ACCEPT
    reason: 'Valid localization.

      '
- term:
    id: GO:0016324
    label: apical plasma membrane
  evidence_type: IDA
  original_reference_id: PMID:31791063
  review:
    summary: 'Direct evidence for apical localization in RPE cells.

      '
    action: ACCEPT
    reason: 'Core localization validated experimentally.

      '
    supported_by:
    - reference_id: PMID:31791063
      supporting_text: 'Quantitative Protein Expression in the Human Retinal Pigment Epithelium: Comparison Between Apical and Basolateral Plasma Membranes With Emphasis on Transporters.'
- term:
    id: GO:0015173
    label: aromatic amino acid transmembrane transporter activity
  evidence_type: IGI
  original_reference_id: PMID:15589117
  review:
    summary: 'LAT1-4F2hc aromatic amino acid transporter activity demonstrated.

      '
    action: ACCEPT
    reason: 'Core molecular function - LAT1 preferentially transports large neutral aromatics.

      '
    supported_by:
    - reference_id: PMID:15589117
      supporting_text: Human LAT1 single nucleotide polymorphism N230K does not alter phenylalanine transport.
- term:
    id: GO:0015823
    label: phenylalanine transport
  evidence_type: IGI
  original_reference_id: PMID:15589117
  review:
    summary: 'Phenylalanine transport by LAT1-4F2hc.

      '
    action: ACCEPT
    reason: 'Core function.

      '
    supported_by:
    - reference_id: PMID:15589117
      supporting_text: Human LAT1 single nucleotide polymorphism N230K does not alter phenylalanine transport.
- term:
    id: GO:0015175
    label: neutral L-amino acid transmembrane transporter activity
  evidence_type: IGI
  original_reference_id: PMID:17197568
  review:
    summary: 'Neutral amino acid transporter activity demonstrated for SLC3A2-containing complexes.

      '
    action: ACCEPT
    reason: 'Core molecular function.

      '
    supported_by:
    - reference_id: PMID:17197568
      supporting_text: Ornithine transport via cationic amino acid transporter-1 is involved in ornithine cytotoxicity in retinal pigment epithelial cells.
- term:
    id: GO:1903801
    label: L-leucine import across plasma membrane
  evidence_type: IGI
  original_reference_id: PMID:17197568
  review:
    summary: 'Leucine import function.

      '
    action: ACCEPT
    reason: 'Core function.

      '
    supported_by:
    - reference_id: PMID:17197568
      supporting_text: Ornithine transport via cationic amino acid transporter-1 is involved in ornithine cytotoxicity in retinal pigment epithelial cells.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: IDA
  original_reference_id: PMID:23137377
  review:
    summary: 'Quantitative proteomics in cerebral microvascular endothelial cells.

      '
    action: ACCEPT
    reason: 'Core localization at blood-brain barrier.

      '
    supported_by:
    - reference_id: PMID:23137377
      supporting_text: Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model.
- term:
    id: GO:1990184
    label: amino acid transport complex
  evidence_type: IDA
  original_reference_id: PMID:30867591
  review:
    summary: 'Cryo-EM structure directly demonstrating SLC3A2 as part of heteromeric amino acid transporter complex.

      '
    action: ACCEPT
    reason: 'Core function - SLC3A2 is an obligate component of HAT complexes.

      '
    supported_by:
    - reference_id: PMID:30867591
      supporting_text: Mar 13. Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex.
- term:
    id: GO:0045296
    label: cadherin binding
  evidence_type: HDA
  original_reference_id: PMID:25468996
  review:
    summary: 'High-throughput study identifying E-cadherin interactome. SLC3A2 localized to cell-cell junctions.

      '
    action: KEEP_AS_NON_CORE
    reason: 'Secondary function related to cell adhesion role.

      '
    supported_by:
    - reference_id: PMID:25468996
      supporting_text: E-cadherin interactome complexity and robustness resolved by quantitative proteomics.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:25998567
  review:
    summary: 'Interaction with LAPTM4B for lysosomal recruitment.

      '
    action: ACCEPT
    reason: 'Functionally important interaction for mTORC1 activation.

      '
    supported_by:
    - reference_id: PMID:25998567
      supporting_text: LAPTM4b recruits the LAT1-4F2hc Leu transporter to lysosomes and promotes mTORC1 activation.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: IDA
  original_reference_id: PMID:25998567
  review:
    summary: 'Plasma membrane and lysosomal localization study.

      '
    action: ACCEPT
    reason: 'Core localization.

      '
    supported_by:
    - reference_id: PMID:25998567
      supporting_text: LAPTM4b recruits the LAT1-4F2hc Leu transporter to lysosomes and promotes mTORC1 activation.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:12270127
  review:
    summary: 'Interaction with CT120/TLCD3A.

      '
    action: KEEP_AS_NON_CORE
    reason: 'Minor interaction - function unclear.

      '
    supported_by:
    - reference_id: PMID:12270127
      supporting_text: Molecular cloning and characterization of CT120, a novel membrane-associated gene involved in amino acid transport and glutathione metabolism.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: IDA
  original_reference_id: PMID:12270127
  review:
    summary: 'Plasma membrane localization.

      '
    action: ACCEPT
    reason: 'Core localization.

      '
    supported_by:
    - reference_id: PMID:12270127
      supporting_text: Molecular cloning and characterization of CT120, a novel membrane-associated gene involved in amino acid transport and glutathione metabolism.
- term:
    id: GO:0009986
    label: cell surface
  evidence_type: IDA
  original_reference_id: PMID:25063885
  review:
    summary: 'Cell surface localization detected - relevant for pathogen binding.

      '
    action: ACCEPT
    reason: 'Valid localization term.

      '
    supported_by:
    - reference_id: PMID:25063885
      supporting_text: 2014 Jul 24. KSHV attachment and entry are dependent on αVβ3 integrin localized to specific cell surface microdomains and do not correlate with the presence of heparan sulfate.
- term:
    id: GO:0009986
    label: cell surface
  evidence_type: HDA
  original_reference_id: PMID:19581412
  review:
    summary: 'Proteomics study on cell surface proteins.

      '
    action: ACCEPT
    reason: 'Valid localization.

      '
    supported_by:
    - reference_id: PMID:19581412
      supporting_text: Jul 6. Quantitative proteomics identifies a Dab2/integrin module regulating cell migration.
- term:
    id: GO:0070062
    label: extracellular exosome
  evidence_type: HDA
  original_reference_id: PMID:23533145
  review:
    summary: 'Detected in prostatic exosomes by proteomics.

      '
    action: KEEP_AS_NON_CORE
    reason: 'Secondary localization - exosomal presence common for membrane proteins.

      '
    supported_by:
    - reference_id: PMID:23533145
      supporting_text: 2013 Apr 23. In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.
- term:
    id: GO:0016020
    label: membrane
  evidence_type: HDA
  original_reference_id: PMID:19946888
  review:
    summary: 'NK cell membrane proteome.

      '
    action: ACCEPT
    reason: 'Valid general localization.

      '
    supported_by:
    - reference_id: PMID:19946888
      supporting_text: Defining the membrane proteome of NK cells.
- term:
    id: GO:0003723
    label: RNA binding
  evidence_type: HDA
  original_reference_id: PMID:22658674
  review:
    summary: 'High-throughput mRNA interactome study detected SLC3A2. This is likely non-specific or secondary.

      '
    action: MARK_AS_OVER_ANNOTATED
    reason: 'SLC3A2 is a membrane transporter chaperone with no known RNA-related function. High-throughput RNA binding studies can capture non-specific associations. No structural or functional evidence supports RNA binding.

      '
    supported_by:
    - reference_id: PMID:22658674
      supporting_text: May 31. Insights into RNA biology from an atlas of mammalian mRNA-binding proteins.
- term:
    id: GO:0070062
    label: extracellular exosome
  evidence_type: HDA
  original_reference_id: PMID:19199708
  review:
    summary: 'Parotid gland exosome proteomics.

      '
    action: KEEP_AS_NON_CORE
    reason: 'Secondary localization.

      '
    supported_by:
    - reference_id: PMID:19199708
      supporting_text: Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT).
- term:
    id: GO:0070062
    label: extracellular exosome
  evidence_type: HDA
  original_reference_id: PMID:19056867
  review:
    summary: 'Urinary exosome proteomics.

      '
    action: KEEP_AS_NON_CORE
    reason: 'Secondary localization.

      '
    supported_by:
    - reference_id: PMID:19056867
      supporting_text: 2008 Dec 3. Large-scale proteomics and phosphoproteomics of urinary exosomes.
- term:
    id: GO:0003725
    label: double-stranded RNA binding
  evidence_type: IDA
  original_reference_id: PMID:21266579
  review:
    summary: 'Study on raftlin involvement in poly(I:C)-mediated TLR3 activation found SLC3A2 in nucleocapture complex. This appears to be a specialized immunological context.

      '
    action: KEEP_AS_NON_CORE
    reason: 'This is a specialized immune function in TLR3 signaling, not a core function of SLC3A2. The dsRNA binding may be indirect through complex formation.

      '
    supported_by:
    - reference_id: PMID:21266579
      supporting_text: 2011 Jan 25. Raftlin is involved in the nucleocapture complex to induce poly(I:C)-mediated TLR3 activation.
- term:
    id: GO:0043330
    label: response to exogenous dsRNA
  evidence_type: IMP
  original_reference_id: PMID:21266579
  review:
    summary: 'Involvement in TLR3 response to poly(I:C).

      '
    action: KEEP_AS_NON_CORE
    reason: 'Specialized immune function, not core transporter role.

      '
    supported_by:
    - reference_id: PMID:21266579
      supporting_text: 2011 Jan 25. Raftlin is involved in the nucleocapture complex to induce poly(I:C)-mediated TLR3 activation.
- term:
    id: GO:0070062
    label: extracellular exosome
  evidence_type: HDA
  original_reference_id: PMID:20458337
  review:
    summary: 'B-cell exosome proteomics.

      '
    action: KEEP_AS_NON_CORE
    reason: 'Secondary localization.

      '
    supported_by:
    - reference_id: PMID:20458337
      supporting_text: 2010 May 11. MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-352191
  review:
    summary: 'Reactome annotation for SLC7A8-mediated uptake with SLC3A2.

      '
    action: ACCEPT
    reason: 'Core localization.

      '
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-352232
  review:
    summary: 'Reactome annotation for SLC7A5:SLC3A2 transport.

      '
    action: ACCEPT
    reason: 'Core localization.

      '
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-375131
  review:
    summary: 'Basigin binding to CD98 complex at plasma membrane.

      '
    action: ACCEPT
    reason: 'Valid localization.

      '
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-376200
  review:
    summary: 'SLC7A10-mediated uptake with SLC3A2.

      '
    action: ACCEPT
    reason: 'Core localization for Asc-1/4F2hc complex.

      '
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-378513
  review:
    summary: 'SLC7A11-mediated cystine/glutamate exchange - system xc-.

      '
    action: ACCEPT
    reason: 'Core localization for xCT/4F2hc (system xc-).

      '
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-379415
  review:
    summary: 'SLC7A7:SLC3A2 arginine/leucine exchange.

      '
    action: ACCEPT
    reason: 'Core localization for y+LAT1/4F2hc.

      '
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-379426
  review:
    summary: 'SLC7A6 (y+LAT2) with SLC3A2.

      '
    action: ACCEPT
    reason: 'Core localization.

      '
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-5660910
  review:
    summary: 'Defective SLC7A7 pathway annotation.

      '
    action: ACCEPT
    reason: 'Valid localization context.

      '
- term:
    id: GO:1903801
    label: L-leucine import across plasma membrane
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: 'Leucine import inferred from sequence similarity.

      '
    action: ACCEPT
    reason: 'Core function consistent with experimental evidence.

      '
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:10506149
  review:
    summary: 'Cloning of b(0,+)-like transporter (SLC7A9 homolog) associating with 4F2hc.

      '
    action: MODIFY
    reason: 'This is heterodimerization with SLC7 family member.

      '
    proposed_replacement_terms:
    - id: GO:0046982
      label: protein heterodimerization activity
    supported_by:
    - reference_id: PMID:10506149
      supporting_text: Cloning and expression of a b(0,+)-like amino acid transporter functioning as a heterodimer with 4F2hc instead of rBAT.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:10631289
  review:
    summary: 'Cloning of asc-1 (SLC7A10) interacting with 4F2hc.

      '
    action: MODIFY
    reason: 'This is heterodimerization with SLC7A10.

      '
    proposed_replacement_terms:
    - id: GO:0046982
      label: protein heterodimerization activity
    supported_by:
    - reference_id: PMID:10631289
      supporting_text: Cloning and functional characterization of a Na(+)-independent, broad-specific neutral amino acid transporter from mammalian intestine.
- term:
    id: GO:0015827
    label: tryptophan transport
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: 'Tryptophan transport from sequence similarity.

      '
    action: ACCEPT
    reason: 'Core function consistent with experimental evidence.

      '
- term:
    id: GO:0006816
    label: calcium ion transport
  evidence_type: NAS
  original_reference_id: PMID:3036867
  review:
    summary: 'This annotation references the original cloning paper from 1987. Early speculation about calcium transport was not confirmed. SLC3A2 functions as an amino acid transporter chaperone, not a calcium transporter.

      '
    action: REMOVE
    reason: 'No evidence supports calcium transport function for SLC3A2. This appears to be a legacy annotation from early characterization before the amino acid transport function was established. Modern structural and functional studies confirm amino acid transport exclusively.

      '
    supported_by:
    - reference_id: PMID:3036867
      supporting_text: Primary structure of the human 4F2 antigen heavy chain predicts a transmembrane protein with a cytoplasmic NH2 terminus.
- term:
    id: GO:0006865
    label: amino acid transport
  evidence_type: TAS
  original_reference_id: PMID:10673541
  review:
    summary: 'Review on heterodimeric amino acid transporters in placenta.

      '
    action: ACCEPT
    reason: 'Core function.

      '
    supported_by:
    - reference_id: PMID:10673541
      supporting_text: 'Heterodimeric amino acid transporters: expression of heavy but not light chains of CD98 correlates with induction of amino acid transport systems in human placental trophoblast.'
- term:
    id: GO:0016020
    label: membrane
  evidence_type: NAS
  original_reference_id: PMID:3476959
  review:
    summary: 'Original cloning paper establishing membrane localization.

      '
    action: ACCEPT
    reason: 'Valid core localization from foundational paper.

      '
    supported_by:
    - reference_id: PMID:3476959
      supporting_text: 'Molecular cloning of complementary DNAs encoding the heavy chain of the human 4F2 cell-surface antigen: a type II membrane glycoprotein involved in normal and neoplastic cell growth.'
- term:
    id: GO:0015327
    label: cystine:glutamate antiporter activity
  evidence_type: IDA
  original_reference_id: PMID:11417227
  review:
    summary: 'SLC3A2/4F2hc partners with xCT/SLC7A11 to form system xc-, the cystine/glutamate antiporter. The complex mediates Na+-independent exchange of extracellular cystine for intracellular glutamate (PMID:11417227, PMID:34880232). This is a core molecular function of the SLC3A2-xCT complex.

      '
    action: NEW
    reason: 'This core molecular function term was not present in existing GOA annotations but is well-supported by multiple experimental studies including the original characterization (PMID:11417227) and recent cryo-EM structures (PMID:34880232). System xc- activity is essential for cysteine homeostasis and ferroptosis regulation.

      '
    supported_by:
    - reference_id: PMID:11417227
      supporting_text: Identification and characterisation of human xCT that co-expresses, with 4F2 heavy chain, the amino acid transport activity system xc-.
    - reference_id: PMID:34880232
      supporting_text: Molecular basis for redox control by the human cystine/glutamate antiporter system xc().
- term:
    id: GO:0006749
    label: glutathione metabolic process
  evidence_type: IMP
  original_reference_id: PMID:34880232
  review:
    summary: 'The xCT-4F2hc (system xc-) complex provides cystine for glutathione biosynthesis. Cystine is reduced to cysteine intracellularly, and cysteine is the rate-limiting substrate for glutathione synthesis. Inhibition of system xc- depletes cellular glutathione leading to ferroptosis.

      '
    action: NEW
    reason: 'SLC3A2 involvement in glutathione metabolism is well-established through its partnership with xCT for cystine import. This biological process is directly downstream of the cystine:glutamate antiporter activity.

      '
    supported_by:
    - reference_id: PMID:34880232
      supporting_text: Molecular basis for redox control by the human cystine/glutamate antiporter system xc().
- term:
    id: GO:0097707
    label: ferroptosis
  evidence_type: IMP
  original_reference_id: PMID:34880232
  review:
    summary: 'Inhibition of the xCT-4F2hc (system xc-) complex leads to cystine starvation, glutathione depletion, and ferroptotic cell death characterized by iron-dependent lipid peroxidation. System xc- is a major target for inducing ferroptosis in cancer therapy.

      '
    action: NEW
    reason: 'SLC3A2 plays a critical regulatory role in ferroptosis through its partnership with xCT. Genetic or pharmacological inhibition of system xc- triggers ferroptosis, establishing SLC3A2 as involved in this cell death process.

      '
    supported_by:
    - reference_id: PMID:34880232
      supporting_text: Molecular basis for redox control by the human cystine/glutamate antiporter system xc().
- term:
    id: GO:0031929
    label: TOR signaling
  evidence_type: NAS
  review:
    summary: Added to align core_functions with existing annotations.
    action: NEW
    reason: Core function term not present in existing_annotations.
    supported_by:
    - reference_id: PMID:9751058
      supporting_text: Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family.
    - reference_id: PMID:25998567
      supporting_text: LAPTM4b recruits the LAT1-4F2hc Leu transporter to lysosomes and promotes mTORC1 activation.
core_functions:
- molecular_function:
    id: GO:0046982
    label: protein heterodimerization activity
  description: SLC3A2/4F2hc forms obligate disulfide-linked heterodimers with SLC7 family light chain transporters (LAT1/SLC7A5, LAT2/SLC7A8, y+LAT1/SLC7A7, y+LAT2/SLC7A6, Asc-1/SLC7A10, xCT/SLC7A11). The heavy chain provides trafficking, plasma membrane localization, and stability for the light chains which provide the catalytic transport activity. Cryo-EM structures have elucidated the heterodimer architecture (PMID:30867591, PMID:33298890, PMID:34880232).
  supported_by:
  - reference_id: PMID:30867591
    supporting_text: Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex resolved at 3.3A resolution
  - reference_id: PMID:34880232
    supporting_text: Molecular basis for redox control by the human cystine/glutamate antiporter system xc resolved by cryo-EM
  locations:
  - id: GO:0005886
    label: plasma membrane
  - id: GO:0005765
    label: lysosomal membrane
- molecular_function:
    id: GO:0015190
    label: L-leucine transmembrane transporter activity
  description: The LAT1-4F2hc (SLC7A5-SLC3A2) complex mediates Na+-independent transport of large neutral amino acids, particularly leucine, which is critical for mTORC1 activation and cell growth. LAT2-4F2hc (SLC7A8-SLC3A2) also transports leucine with broader substrate specificity. This function is essential for nutrient sensing and cell proliferation.
  supported_by:
  - reference_id: PMID:9751058
    supporting_text: Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family established leucine as key substrate
  - reference_id: PMID:25998567
    supporting_text: LAPTM4b recruits the LAT1-4F2hc Leu transporter to lysosomes for mTORC1 activation
  locations:
  - id: GO:0005886
    label: plasma membrane
  - id: GO:0005765
    label: lysosomal membrane
  directly_involved_in:
  - id: GO:0031929
    label: TOR signaling
- molecular_function:
    id: GO:0015327
    label: cystine:glutamate antiporter activity
  description: The xCT-4F2hc (SLC7A11-SLC3A2) complex functions as system xc-, a cystine/glutamate antiporter that imports cystine in exchange for glutamate. This activity is essential for maintaining intracellular cysteine levels required for glutathione synthesis. The system xc- transporter is a critical regulator of ferroptosis - inhibition leads to iron-dependent lipid peroxidation and cell death (PMID:34880232, PMID:11417227).
  supported_by:
  - reference_id: PMID:11417227
    supporting_text: Identification and characterisation of human xCT that co-expresses, with 4F2 heavy chain, the amino acid transport activity system xc-
  - reference_id: PMID:34880232
    supporting_text: Molecular basis for redox control by the human cystine/glutamate antiporter system xc structure and function
  locations:
  - id: GO:0005886
    label: plasma membrane
  directly_involved_in:
  - id: GO:0006749
    label: glutathione metabolic process
  - id: GO:0097707
    label: ferroptosis
- molecular_function:
    id: GO:0015173
    label: aromatic amino acid transmembrane transporter activity
  description: LAT1-4F2hc preferentially transports large neutral aromatic amino acids including phenylalanine, tyrosine, and tryptophan. This transport activity is Na+-independent and operates in exchange mode. LAT1 also transports thyroid hormones (T3, T4) which are structurally similar to tyrosine (PMID:11564694). LAT1 overexpression in tumors supports increased amino acid demand for cancer cell proliferation.
  supported_by:
  - reference_id: PMID:15589117
    supporting_text: LAT1-4F2hc aromatic amino acid transporter activity demonstrated with phenylalanine as substrate
  - reference_id: PMID:11564694
    supporting_text: Thyroid hormone transport by the heterodimeric human system L amino acid transporter
  locations:
  - id: GO:0005886
    label: plasma membrane
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO terms
  findings: []
- id: GO_REF:0000024
  title: Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000043
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
  findings: []
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping
  findings: []
- id: GO_REF:0000052
  title: Gene Ontology annotation based on curation of immunofluorescence data
  findings: []
- id: GO_REF:0000107
  title: Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
  findings: []
- id: GO_REF:0000117
  title: Electronic Gene Ontology annotations created by ARBA machine learning models
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: PMID:3036867
  title: Primary structure of the human 4F2 antigen heavy chain
  findings:
  - statement: Original cloning paper establishing SLC3A2 as a type II transmembrane glycoprotein
- id: PMID:3476959
  title: 'Molecular cloning of complementary DNAs encoding the heavy chain of the human 4F2 cell-surface antigen: a type II membrane glycoprotein involved in normal and neoplastic cell growth.'
  findings:
  - statement: Foundational characterization of SLC3A2
- id: PMID:9751058
  title: Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family
  findings:
  - statement: Established that 4F2hc forms heterodimers with permease light chains for amino acid transport
- id: PMID:9878049
  title: Amino acid transport of y+L-type by heterodimers of 4F2hc/CD98
  findings:
  - statement: Characterized y+L amino acid transport by 4F2hc heterodimers
- id: PMID:10391915
  title: Identification of a membrane protein, LAT-2, that Co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids.
  findings:
  - statement: Discovery of LAT2/SLC7A8 as 4F2hc partner
- id: PMID:10574970
  title: LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter
  findings:
  - statement: Characterization of LAT2-4F2hc in kidney and intestine
- id: PMID:10903140
  title: The heterodimeric amino acid transporter 4F2hc/y+LAT2 mediates arginine efflux
  findings:
  - statement: Established y+LAT2/4F2hc arginine/glutamine exchange
- id: PMID:11311135
  title: Association of 4F2hc with light chains LAT1, LAT2 or y+LAT2 requires different domains
  findings:
  - statement: Domain mapping for light chain interactions
- id: PMID:11417227
  title: Identification and characterisation of human xCT that co-expresses, with 4F2 heavy chain, the amino acid transport activity system xc-.
  findings:
  - statement: Discovery of xCT/SLC7A11 as system xc- light chain partner of 4F2hc
  - statement: Cystine/glutamate antiporter activity established
- id: PMID:11557028
  title: Human L-type amino acid transporter 1 (LAT1) characterization
  findings:
  - statement: Comprehensive LAT1-4F2hc functional characterization in tumor cells
- id: PMID:11564694
  title: Thyroid hormone transport by the heterodimeric human system L amino acid transporter
  findings:
  - statement: Demonstrated T3/T4 transport by system L
- id: PMID:25998567
  title: LAPTM4b recruits the LAT1-4F2hc Leu transporter to lysosomes
  findings:
  - statement: Lysosomal recruitment and mTORC1 activation mechanism
- id: PMID:30341327
  title: Hepatitis C Virus Modulates Solute carrier family 3 member 2 for Viral Propagation.
  findings:
  - statement: HCV exploits SLC3A2 for entry and mTORC1 activation
- id: PMID:30867591
  title: Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex
  findings:
  - statement: First cryo-EM structure of LAT1-4F2hc at 3.3A resolution
  - statement: Revealed heterodimer architecture and disulfide linkage
- id: PMID:33298890
  title: Structural insight into the substrate recognition and transport mechanism of the human LAT2-4F2hc complex.
  findings:
  - statement: Cryo-EM structure of LAT2-4F2hc with substrates
- id: PMID:33758168
  title: Mechanism of substrate transport and inhibition of the human LAT1-4F2hc amino acid transporter.
  findings:
  - statement: Transport mechanism and inhibitor binding details
- id: PMID:34294905
  title: Plasmodium vivax binds host CD98hc (SLC3A2) to enter immature red blood cells.
  findings:
  - statement: SLC3A2 serves as malaria parasite receptor
- id: PMID:34880232
  title: Molecular basis for redox control by the human cystine/glutamate antiporter system xc
  findings:
  - statement: Cryo-EM structure of xCT/SLC7A11-4F2hc complex
  - statement: Ferroptosis protection mechanism
- id: Reactome:R-HSA-378513
  title: SLC7A11-mediated exchange of extracellular cysteine and cytosolic glutamate
  findings:
  - statement: System xc- pathway annotation
- id: PMID:10506149
  title: Cloning and expression of a b(0,+)-like amino acid transporter functioning as a heterodimer with 4F2hc instead of rBAT. A new candidate gene for cystinuria.
  findings: []
- id: PMID:10631289
  title: Cloning and functional characterization of a Na(+)-independent, broad-specific neutral amino acid transporter from mammalian intestine.
  findings: []
- id: PMID:10673541
  title: 'Heterodimeric amino acid transporters: expression of heavy but not light chains of CD98 correlates with induction of amino acid transport systems in human placental trophoblast.'
  findings: []
- id: PMID:10734121
  title: Identification and characterization of a Na(+)-independent neutral amino acid transporter that associates with the 4F2 heavy chain and exhibits substrate selectivity for small neutral D- and L-amino acids.
  findings: []
- id: PMID:12225859
  title: Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells.
  findings: []
- id: PMID:12270127
  title: Molecular cloning and characterization of CT120, a novel membrane-associated gene involved in amino acid transport and glutathione metabolism.
  findings: []
- id: PMID:15589117
  title: Human LAT1 single nucleotide polymorphism N230K does not alter phenylalanine transport.
  findings: []
- id: PMID:15769744
  title: 'Identification of stereoselective transporters for S-nitroso-L-cysteine: role of LAT1 and LAT2 in biological activity of S-nitrosothiols.'
  findings: []
- id: PMID:17197568
  title: Ornithine transport via cationic amino acid transporter-1 is involved in ornithine cytotoxicity in retinal pigment epithelial cells.
  findings: []
- id: PMID:19056867
  title: Large-scale proteomics and phosphoproteomics of urinary exosomes.
  findings: []
- id: PMID:19199708
  title: Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT).
  findings: []
- id: PMID:19581412
  title: Quantitative proteomics identifies a Dab2/integrin module regulating cell migration.
  findings: []
- id: PMID:19946888
  title: Defining the membrane proteome of NK cells.
  findings: []
- id: PMID:20374249
  title: The pathogenic E. coli type III effector EspZ interacts with host CD98 and facilitates host cell prosurvival signalling.
  findings: []
- id: PMID:20458337
  title: MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis.
  findings: []
- id: PMID:21266579
  title: Raftlin is involved in the nucleocapture complex to induce poly(I:C)-mediated TLR3 activation.
  findings: []
- id: PMID:22658674
  title: Insights into RNA biology from an atlas of mammalian mRNA-binding proteins.
  findings: []
- id: PMID:23137377
  title: Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model.
  findings: []
- id: PMID:23533145
  title: In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.
  findings: []
- id: PMID:25063885
  title: "KSHV attachment and entry are dependent on αVβ3 integrin localized to specific cell surface microdomains and do not correlate with the presence of heparan sulfate."
  findings: []
- id: PMID:25468996
  title: E-cadherin interactome complexity and robustness resolved by quantitative proteomics.
  findings: []
- id: PMID:27912058
  title: Impaired Amino Acid Transport at the Blood Brain Barrier Is a Cause of Autism Spectrum Disorder.
  findings: []
- id: PMID:28112518
  title: LC-MS/MS Based Quantitation of ABC and SLC Transporter Proteins in Plasma Membranes of Cultured Primary Human Retinal Pigment Epithelium Cells and Immortalized ARPE19 Cell Line.
  findings: []
- id: PMID:28298427
  title: Systematic protein-protein interaction mapping for clinically relevant human GPCRs.
  findings: []
- id: PMID:31791063
  title: 'Quantitative Protein Expression in the Human Retinal Pigment Epithelium: Comparison Between Apical and Basolateral Plasma Membranes With Emphasis on Transporters.'
  findings: []
- id: PMID:35271311
  title: 'OpenCell: Endogenous tagging for the cartography of human cellular organization.'
  findings: []
- id: PMID:40355756
  title: The solute carrier superfamily interactome.
  findings: []
- id: Reactome:R-HSA-352191
  title: SLC7A8-mediated uptake of neutral amino acids
  findings: []
- id: Reactome:R-HSA-352232
  title: SLC7A5:SLC3A2 transports neutral amino acids from extracellular region to cytosol
  findings: []
- id: Reactome:R-HSA-375131
  title: Basigin binds CD98 complex
  findings: []
- id: Reactome:R-HSA-376200
  title: SLC7A10-mediated uptake of small neutral amino acids
  findings: []
- id: Reactome:R-HSA-379415
  title: SLC7A7:SLC3A2 exchanges L-Arg for L-Leu, Na+ across the plasma membrane
  findings: []
- id: Reactome:R-HSA-379426
  title: SLC7A6 (y+LAT2)-mediated exchange of extracellular leucine for cytosolic arginine
  findings: []
- id: Reactome:R-HSA-5660910
  title: Defective SLC7A7 does not exchange L-Arg for L-Leu, Na+ across the plasma membrane
  findings: []
- id: file:human/SLC3A2/SLC3A2-deep-research-falcon.md
  title: Deep research report on SLC3A2
  findings: []
tags:
- ferroptosis